WO2014123659A1 - Vascular device aneurysm treatment and providing blood flow into a perforator vessel - Google Patents

Vascular device aneurysm treatment and providing blood flow into a perforator vessel Download PDF

Info

Publication number
WO2014123659A1
WO2014123659A1 PCT/US2014/011198 US2014011198W WO2014123659A1 WO 2014123659 A1 WO2014123659 A1 WO 2014123659A1 US 2014011198 W US2014011198 W US 2014011198W WO 2014123659 A1 WO2014123659 A1 WO 2014123659A1
Authority
WO
WIPO (PCT)
Prior art keywords
apertures
vascular device
strands
pores
vascular
Prior art date
Application number
PCT/US2014/011198
Other languages
French (fr)
Inventor
Richard Kusleika
Original Assignee
Covidien Lp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Covidien Lp filed Critical Covidien Lp
Priority to EP14703465.6A priority Critical patent/EP2953552B1/en
Publication of WO2014123659A1 publication Critical patent/WO2014123659A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12027Type of occlusion
    • A61B17/12036Type of occlusion partial occlusion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12168Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
    • A61B17/12172Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/844Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents folded prior to deployment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/856Single tubular stent with a side portal passage
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04CBRAIDING OR MANUFACTURE OF LACE, INCLUDING BOBBIN-NET OR CARBONISED LACE; BRAIDING MACHINES; BRAID; LACE
    • D04C1/00Braid or lace, e.g. pillow-lace; Processes for the manufacture thereof
    • D04C1/02Braid or lace, e.g. pillow-lace; Processes for the manufacture thereof made from particular materials
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04CBRAIDING OR MANUFACTURE OF LACE, INCLUDING BOBBIN-NET OR CARBONISED LACE; BRAIDING MACHINES; BRAID; LACE
    • D04C1/00Braid or lace, e.g. pillow-lace; Processes for the manufacture thereof
    • D04C1/06Braid or lace serving particular purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00526Methods of manufacturing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00867Material properties shape memory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2002/823Stents, different from stent-grafts, adapted to cover an aneurysm

Definitions

  • Lumens in a patient's body can change in size, shape, and/or patency, and such changes can present complications or affect associated bodily functions.
  • the walls of the vasculature particularly arterial walls, may develop a pathological dilatation, commonly called an aneurysm.
  • Aneurysms are observed as a ballooning-out of the wall of an artery. This is a result of the vessel wall being weakened by disease, injury, or a congenital abnormality. Aneurysms have thin, weak walls and have a tendency to rupture and are often caused or made worse by high blood pressure.
  • Aneurysms can be found in different parts of the body; the most common being abdominal aortic aneurysms (AAA) and the brain or cerebral aneurysms.
  • AAA abdominal aortic aneurysms
  • the mere presence of an aneurysm is not always life-threatening, but an aneurysm can have serious health consequences such as a stroke if one should rupture in the brain. Additionally, a ruptured aneurysm can also result in death.
  • a vascular device comprising:
  • a body having a first, collapsed configuration and a second, expanded configuration, the body comprised of a plurality of heat-set strands; wherein the strands are braided such that when the body is in the second configuration, the strands form a plurality of pores and a plurality of apertures between the strands;
  • apertures are disposed at a longitudinal center region of the body
  • the pores at proximal and distal portions of the body are generally uniform in size and smaller in size than the apertures;
  • pores and the apertures are substantially the same size when the body is in the first configuration.
  • the vascular device of clause 1 wherein the plurality of apertures comprises four apertures. 10. The vascular device of clause 9, wherein the apertures are equally spaced and radially arranged around a longitudinal axis of the body.
  • a method, for creating a plurality of apertures in a vascular device comprising:
  • each of the apertures by displacing strands disposed at a longitudinal center region of the device with a tapered mandrel, wherein each aperture is larger than a pore;
  • a method for providing blood flow into a perforator vessel extending from a sac of an aneurysm comprising:
  • vascular device positioning a vascular device in a vessel at an opening into the aneurysm, wherein the device has a first, collapsed configuration and a second, expanded configuration, the device comprising:
  • strands are braided such that when the device is in the second configuration, the strands form a plurality of pores and a plurality of apertures between the strands;
  • apertures are disposed at a longitudinal center region of the device
  • the pores at proximal and distal portions of the device are generally uniform in size and smaller in size than the apertures;
  • pores and the apertures are substantially the same size when the device is in the first configuration; and aligning the longitudinal center region of the device with the aneurysm to thereby provide blood flow into the perforator through one of the apertures.
  • FIG. 1A depicts a vascular device in a collapsed configuration, according to some embodiments of the subject technology.
  • FIG. IB depicts a vascular device in an expanded configuration, according to some embodiments of the subject technology.
  • FIG. 1C depicts a detail view of an aperture, according to some embodiments of the subject technology.
  • FIG. ID depicts a cross section taken at a longitudinal center of a vascular device, according to some embodiments of the subject technology.
  • FIG. IE depicts a cross section taken at a proximal region of a vascular device, according to some embodiments of the subject technology.
  • FIG. IF depicts a cross section taken at a distal region of a vascular device, according to some embodiments of the subject technology.
  • FIG. 2 depicts a cross section view of a vessel and delivery of a vascular device, according to some embodiments of the subject technology.
  • FIG. 3 depicts a cross section view of a vessel and delivery of a vascular device, according to some embodiments of the subject technology.
  • FIG. 4 depicts a cross section view of a vessel and delivery of a vascular device, according to some embodiments of the subject technology.
  • FIG. 5 depicts a cross section view of a vessel and delivery of a vascular device, according to some embodiments of the subject technology.
  • FIG. 6 depicts a cross section view of a vessel and deployed vascular device, according to some embodiments of the subject technology.
  • Aneurysms may be located, for example, along vessel side walls.
  • a neck of an aneurysm typically defines an opening of between about 2 to 25 mm, though other sizes and ranges are also possible.
  • the neck connects an anatomical vessel lumen to a fundus of the aneurysm.
  • "vessel” may refer to blood vessels (including arteries and veins) or other suitable body organs having a lumen, such as the gastrointestinal tract (e.g., esophagus, stomach, small intestine, colon, rectum), bile ducts, urinary bladder, ureter, urethra, trachea, bronchi, and the like.
  • Blood flow within the anatomical lumen is channeled through the neck and into the fundus.
  • the wall of the aneurysm continues to distend and presents a significant risk of rupturing.
  • the aneurysm ruptures.
  • Reduction of blood flow to or within the aneurysm results in a reduction in force against the wall of the aneurysm and a corresponding reduction in the risk of rupturing.
  • a reduction of the force and volume of blood entering the aneurysm may be accomplished by an occluding device.
  • the conventional occluding device restricts blood flow to the aneurysm.
  • the aneurysm may have small perforator vessels or arteries extending from the aneurysm.
  • any small perforator arteries or vessel branches (both inlet and outlet branches) extending from the aneurysm are also occluded, thereby preventing blood from flowing into the perforator vessels.
  • the vascular devices of the subject technology solve some or all of the foregoing problems by sufficiently restricting the blood flow into the aneurysm to prevent rupture while providing sufficient blood flow to perforator vessels or arteries extending from the aneurysm, or extending from the parent vessel sidewall near the aneurysm neck (and/or from a location on the sidewall between the proximal and distal ends of the vascular device when deployed).
  • the vascular device includes an expandable vascular device having one or more enlarged apertures disposed near the neck of the aneurysm.
  • the vascular device is configured to reduce the laminar flow into the aneurysm to prevent rupture, while providing sufficient blood flow to the perforator vessel through one or more of the enlarged apertures. Accordingly, the vascular device exhibits a porosity configured to reduce haemodynamic flow into the aneurysm, but simultaneously allow perfusion to perforator vessels.
  • FIGS. 1A-1F depict a vascular device 100, according to some embodiments of the subject technology.
  • the vascular device 100 comprises a body 110 having a first, collapsed configuration and a second, expanded configuration.
  • the body is comprised of a plurality of heat-set strands 112 that are braided such that when the body 110 is in the expanded configuration, the strands 112 form a plurality of pores 120 and a plurality of apertures 130 between the strands 112, as shown in FIG. IB.
  • the pores 120 at proximal and distal portions of the body 110 are generally uniform in size and smaller in size than the apertures 130. Referring to FIG.
  • the body 110 may be a self-expanding stent made of two or more round or ovoid wire strands or filaments 112.
  • the filaments may all be of the same thickness.
  • the thickness of each strand 112 may be about 0.0001 to 0.0020 inches.
  • the filaments may be formed of known flexible and shape memory materials, such as nitinol, platinum and stainless steel.
  • the body 110 may be fabricated from platinum/8% tungsten and 35N LT (cobalt nickel alloy, which is a low titanium version of MP35N alloy) alloy wires.
  • one or more of the filaments can be formed of a biocompatible metal material or a biocompatible polymer, so long as the filaments are flexible and have shape memory properties.
  • the filaments may be braided into a resulting lattice-like structure.
  • the filaments may be loosely braided using a 1-over- 2-under-2 system. In other embodiments, however, other methods of braiding may be followed, without departing from the scope of the disclosure.
  • the ends of the body 110 may be cut to length and therefore remain free for radial expansion and contraction.
  • the body 110 may exhibit a high degree of flexibility due to the materials used, the porosity of the body 110, and the fact that the ends of the filaments are not secured to each other.
  • the pores 120 at the proximal and distal portions of the body 110 are sized to reduce haemodynamic flow into an aneurysm and the apertures 130 are sized to provide sufficient blood flow to any perforator vessels extending from the aneurysm.
  • an area of at least one of the pores 120 may be about 0.01 square millimeters or less and an area of at least one of the apertures 130 may be about 0.005 square millimeters or more.
  • the apertures 130 are larger than the pores 120.
  • the apertures 130 are configured to be about five times the size of the pores 120.
  • the apertures 130 are sized to be range from about two to about ten times the size of the pores 120, while in some embodiments, the apertures 130 are sized to range from about three to about seven times the size of the pores 120.
  • the apertures 130 may be disposed at a longitudinal center region of the body 110 and be formed by displacement of adjacent strands, as shown in FIG. 1C.
  • the vascular device 100 may have two apertures 130 disposed at the longitudinal center region of the body 110.
  • the vascular device 100 may have three apertures 130 disposed at the longitudinal center region of the body 110.
  • the vascular device 100 may have four apertures 130 disposed at the longitudinal center region of the body 110.
  • FIGS. 1A-D depict four apertures 130, it is understood that a number of apertures greater than four may be suitable for many applications.
  • the apertures 130 may be equally spaced and radially arranged around a longitudinal axis 140 of the body.
  • a center region 132 of each of the apertures 130 is disposed along a single radial cross section of the body 110, as shown in FIG. ID.
  • the pores 120 and the apertures 130 generally comprise gaps, voids, or areas that are formed between adjacent strands 112
  • the number of strands 112 in each of a proximal, center, and distal radial cross sections of the body 1 10 is the same.
  • the number of strands 112 shown at the proximal cross section of the body 110, shown in FIG. IE is the same as the number of strands 112 shown at the center cross section of the body 110, shown in FIG. ID, and the distal cross section of the body 110, shown in FIG. IF.
  • the body 110 has a hoop strength that is generally uniform along the body's 110 longitudinal length.
  • the apertures 130 may be formed on the vascular device 100 by first placing the vascular device 100 in the expanded configuration on a fixture and then inserting one or more tapered mandrels, depending on the number of apertures 130, through the body 110 to displace the strands 112 and thereby form the apertures 130.
  • the displaced strands 112 are then heated to their shape memory temperature to "set" the displaced strands in their displaced configuration. Thereafter, the one or more mandrels are removed from the body 110 and the apertures 130 remain formed on the body 110.
  • the displaced strands 112 forming the apertures 130 are collapsed, along with all the strands 112 comprising the body 110, and the apertures 130 and the pores 120 are substantially the same size, as shown in FIG. 1 A.
  • the vascular device may be coated with an endothelial progenitor cell coating to promote endothelium growth on an inner surface of the vascular device 100.
  • the endothelium will grow from the proximal and/or distal ends of the vascular device 100 and traverse toward the longitudinal center of the vascular device 100.
  • the strands 112 of the vascular device 100 serve as a substrate for the cells to attach thereto.
  • the pores 120 are occluded. Because the apertures 130 are larger than the pores 120, the endothelium grows around the apertures 130 but does not occlude the apertures 130.
  • the apertures 130 remain unobstructed and permit blood to flow therethrough to feed any perforator vessel emanating from an aneurysm fundus, or emanating from the parent vessel sidewall near the aneurysm neck (and/or from a location on the sidewall between the proximal and distal ends of the vascular device when deployed).
  • Radiopaque markers may be located adjacent the proximal or distal portions of the vascular device 100, and may be located at any position along the length of the vascular device 100 between a proximal and distal end of the vascular device 100.
  • the markers may be attached to the vascular device 100 by techniques such as adhesives, heat fusion, interference fit, fasteners, intermediate members, coatings, or by other techniques.
  • the markers are comprised of ultrasonic markers, MRI-safe markers, or other markers.
  • ultrasonic markers permit a physician to accurately determine the position of the vascular device 100 within a patient under ultrasonic visualization.
  • Materials for an ultrasonic marker have an acoustical density sufficiently different from the vascular device 100 to provide suitable visualization via ultrasonic techniques.
  • Exemplary materials comprise polymers, metals such as tantalum, platinum, gold, tungsten and alloys of such metals, hollow glass spheres or microspheres, and other materials.
  • MRI-safe markers permit a physician to accurately determine the position of the vascular device 100 within a patient under magnetic resonance imaging.
  • Exemplary materials for making MRI-safe marker have a magnetic signature sufficiently different from the vascular device 100 to provide suitable visualization via MRI techniques.
  • Exemplary materials comprise polymers, metals such as tantalum, platinum, gold, tungsten and alloys of such metals, non-ferrous materials, and other materials.
  • the vascular device 100 may be delivered to a treatment site using a delivery system 200.
  • the delivery system 200 may include a catheter, which may for example, be an over the wire (OTW) catheter, a rapid exchange (multiple lumen) catheter, or a fixed wire catheter.
  • OGW over the wire
  • MCP multiple lumen
  • an outer sheath 210 Prior to delivery, an outer sheath 210 is disposed over the vascular device 100 to confine the vascular device 100 in the first, collapsed configuration.
  • the vascular device 100 is cooperatively movable within the outer sheath 210 in order to deliver the vascular device 100 to a treatment site, such as an aneurysm 310, within the vasculature 300 of a patient.
  • the outer sheath 210 may be configured to be introduced and advanced through the vasculature of the patient.
  • the outer sheath 210 may be made from various thermoplastics, e.g., PTFE, FEP, HDPE, PEEK, etc., which may optionally be lined on the inner surface of the outer sheath 140 or an adjacent surface with a hydrophilic material such as PVP or some other plastic coating. Additionally, either surface may be coated with various combinations of different materials, depending upon the desired results.
  • the delivery system 200 also includes a shaft 220 and a guide wire 230.
  • the shaft 220 has a guide wire lumen for allowing the guide wire 230 to extend therethrough.
  • the shaft 220 may also include a reduced diameter at a distal region to provide sufficient annular space in which the vascular device 100 may be stowed.
  • Radiopaque markers may be provided at various locations along the length of the delivery system 200.
  • an enlarged distal tip 240 of the shaft 220 may be radiopaque.
  • radiopaque markers may be provided on the reduced diameter distal region of the shaft 220, beneath the distal and proximal end of the vascular device 100.
  • a radiopaque marker 250 may be disposed on the shaft 220 adjacent to a longitudinal center of the vascular device 100, corresponding to the location of the apertures 130.
  • the vascular device 100 may be configured with differently sized apertures 130 and/or number of apertures 130. A physician may therefore select the appropriate vascular device 100 based on a size of the aneurysm and/or a number of perforators extending from the aneurysm and the diameter of each aperture 130 and/or number of apertures 130 per vascular device 100.
  • the vascular device 100 may be selected such that the apertures 130 in fluid communication with the sac (and/or with other relevant vessel location(s)) are sufficiently large to provide sufficient blood flow to each of the perforators when the vascular device 100 is in the second, expanded configuration.
  • the blood flow permitted by the apertures 130 to the perforators is sufficient to provide blood to downstream tissues without inducing ischemia.
  • the vascular device 100 may be selected such that there are a sufficient number of apertures 130 in fluid communication with the sac (and/or with other relevant vessel location(s)) to provide sufficient blood flow to each of the perforators when the vascular device 100 is in the second, expanded configuration.
  • sufficient blood flow is provided for the perforators extending from the aneurysm sac and/or parent vessel 300 to avoid or limit ischemia to downstream tissue, but the blood flow within the aneurysm is disrupted sufficiently to permit healing of the aneurysm.
  • the delivery system 200 is advanced percutaneously over the guide wire 230, in this example, to the site of the aneurysm 310 having a perforator vessel 320 extending therefrom.
  • the outer sheath 210 is withdrawn proximally while maintaining the position of the shaft 220 to thereby expose a distal portion of the shaft 220 and the vascular device 100.
  • the outer sheath 210 is withdrawn until a distal end of the outer sheath 210 is proximal of the vascular device 100.
  • the vascular device 100 expands.
  • the apertures 130 may begin to take form due to the shape memory properties of the strands 112.
  • the delivery system 200 may be adjusted or withdrawn proximally during deployment, until the radiopaque marker 250 and hence the apertures 130 are centered along the length of the ostium or neck of the aneurysm 310 and/or located on either side of the ostium, as appropriate.
  • the longitudinal center region of the vascular device 100 is aligned with the aneurysm 310 to thereby provide blood flow into the perforator 320 through one of the apertures 130.
  • the longitudinal center region of the vascular device 100 is centered along the length of the ostium so that at least one aperture 130 provides blood flow to the perforator 320 when the vascular device 110 is in the second, expanded configuration.
  • the position of the vascular device 100 within the vessel 300 may be further modified, if after initial partial deployment of the vascular device 100, the vascular device is positioned incorrectly or otherwise has to be relocated to properly cover the treatment site.
  • the outer sheath 210 may be advanced distally, thereby encapsulating or compressing the vascular device 100 within the outer sheath 210 and allowing the system 200 to be repositioned.
  • the vascular device 100 may be partially deployed, resheathed, and relocated multiple times in order to ensure that the vascular device is properly deployed in the correct location.
  • the strands of the vascular device 100 can also move relative to each other, further allowing the vascular device 100 to flex and thereby permit advancement or rotation of the unexpanded portion of the vascular device 100 against an expanded portion of the vascular device 100 that is deployed within the vessel 300. Accordingly, through rotation or positioning of the unexpanded portion relative to the expanded portion of the vascular device 100, the apertures 130 of the vascular device 100 may be properly aligned and positioned at the treatment site.
  • the catheter, along with the outer sheath 210, shaft 220, and guide wire 230 may be withdrawn from the patient.
  • blood may flow to the perforator vessel 320 from the plurality of pores 120 and apertures 130.
  • the pores 120 will become occluded thereby preventing blood from flowing therethrough.
  • the blood will continue to flow through the apertures 130, thereby providing sufficient blood flow to the perforator 320.
  • the vascular device 100 may be comprised of metal, polymer, ceramic, permanent enduring materials, and may comprise either or both of non-bioabsorbable and bioabsorbable materials.
  • Exemplary materials include, but are not limited to, NITINOL®, stainless steel, cobalt chromium alloys, Elgiloy, magnesium alloys, polylactic acid, poly glycolic acid, poly ester amide (PEA), poly ester urethane (PEU), amino acid based bioanalogous polymers, tungsten, tantalum, platinum, polymers, bio-polymers, ceramics, bio-ceramics, or metallic glasses.
  • the medical device may elute over time substances such as drugs, biologies, gene therapies, antithrombotics, coagulants, anti-inflammatory drugs, immunomodulator drugs, anti-proliferatives, migration inhibitors, extracellular matrix modulators, healing promoters, re-endothelialization promoters, or other materials.
  • the vascular device 100 may be formed from materials having shape memory properties.
  • the vascular device 100 may be finished by processes to remove slag.
  • the vascular device 100 may be subjected to a tempering treatment at temperatures customarily applied to the material so that the impressed structure is permanently established.
  • the vascular device 100 may have various lengths and diameters.
  • the vascular device 100 may have specific cross-sectional diameters, the diameters being measured when the vascular device 110 is fully free to expand, ranging from about 2 mm to about 6 mm. If the vascular device 110 has a diameter between about 3 mm and about 4 mm, it may be used in a size 18 microcatheters (i.e., microcatheters with an inner diameter of approximately 0.21 inch). If the vascular device 100 has a diameter between about 5 mm and about 6 mm, it may be used in a size 27 microcatheters (i.e., microcatheters with an inner diameter of approximately 0.027 inch).
  • the vascular device 100 may have lengths, measured proximally to distally along the longitudinal axis of the vascular device 100, ranging from about 15 mm to about 40 mm, though other ranges and sizes are also possible.
  • Skilled artisans may implement the described functionality in varying ways for each particular application. Various components and blocks may be arranged differently (for example, arranged in a different order, or partitioned in a different way) all without departing from the scope of the subject technology. It is understood that the specific order or hierarchy of steps in the processes disclosed is an illustration of exemplary approaches. Based upon design preferences, it is understood that the specific order or hierarchy of steps in the processes may be rearranged. Some of the steps may be performed simultaneously. The accompanying method claims present elements of the various steps in a sample order, and are not meant to be limited to the specific order or hierarchy presented.
  • a phrase such as an "aspect” does not imply that such aspect is essential to the subject technology or that such aspect applies to all configurations of the subject technology.
  • a disclosure relating to an aspect may apply to all configurations, or one or more configurations.
  • An aspect may provide one or more examples.
  • a phrase such as an aspect may refer to one or more aspects and vice versa.
  • a phrase such as an "aspect” does not imply that such aspect is essential to the subject technology or that such aspect applies to all configurations of the subject technology.
  • a disclosure relating to an aspect may apply to all aspects, or one or more aspects.
  • An aspect may provide one or more examples.
  • a phrase such as an "aspect” may refer to one or more aspects and vice versa.
  • a phrase such as a "configuration” does not imply that such configuration is essential to the subject technology or that such configuration applies to all configurations of the subject technology.
  • a disclosure relating to a configuration may apply to all configurations, or one or more configurations.
  • a configuration may provide one or more examples.
  • a phrase such as a "configuration” may refer to one or more configurations and vice versa.

Abstract

A vascular device (100) includes a body (110) having a first, collapsed configuration and a second, expanded configuration. The body includes a plurality of heat-set strands (112) that are braided such that when the body is in the second configuration, the strands form a plurality of pores (120) and one or more apertures (130) between the strands. The apertures are generally disposed at a longitudinal center region of the body. When the body is in the second configuration, the pores at proximal and distal portions of the body are generally uniform in size and smaller in size than the apertures. The pores and the apertures are substantially the same size when the body is in the first configuration.

Description

VASCULAR DEVICE FOR ANEURYSM TREATMENT AND PROVIDING BLOOD
FLOW INTO A PERFORATOR VESSEL
RELATED APPLICATIONS
[0001] This application claims priority to U.S. Patent Application No. 13/826,147, filed on March 14, 2013, titled "Vascular Device for Aneurysm Treatment and Providing Blood Flow into a Perforator Vessel"; and to U.S. Provisional Patent Application No. 61/760,907, filed on February 5, 2013, titled "Vascular Device for Aneurysm Treatment and Providing Blood Flow into a Perforator Vessel." The entire contents of the above -noted applications are incorporated by reference herein and made a part of this specification.
BACKGROUND
[0002] Lumens in a patient's body can change in size, shape, and/or patency, and such changes can present complications or affect associated bodily functions. For example, the walls of the vasculature, particularly arterial walls, may develop a pathological dilatation, commonly called an aneurysm. Aneurysms are observed as a ballooning-out of the wall of an artery. This is a result of the vessel wall being weakened by disease, injury, or a congenital abnormality. Aneurysms have thin, weak walls and have a tendency to rupture and are often caused or made worse by high blood pressure. Aneurysms can be found in different parts of the body; the most common being abdominal aortic aneurysms (AAA) and the brain or cerebral aneurysms. The mere presence of an aneurysm is not always life-threatening, but an aneurysm can have serious health consequences such as a stroke if one should rupture in the brain. Additionally, a ruptured aneurysm can also result in death.
SUMMARY
[0003] The subject technology is illustrated, for example, according to various aspects described below. Various examples of aspects of the subject technology are described as numbered clauses (1, 2, 3, etc.) for convenience. These are provided as examples, and do not limit the subject technology. It is noted that any of the dependent clauses may be combined in any combination, and placed into a respective independent clause, e.g., clause 1, 18 and 27. The other clauses can be presented in a similar manner.
1. A vascular device, comprising:
a body having a first, collapsed configuration and a second, expanded configuration, the body comprised of a plurality of heat-set strands; wherein the strands are braided such that when the body is in the second configuration, the strands form a plurality of pores and a plurality of apertures between the strands;
wherein the apertures are disposed at a longitudinal center region of the body;
wherein, when the body is in the second configuration, the pores at proximal and distal portions of the body are generally uniform in size and smaller in size than the apertures; and
wherein the pores and the apertures are substantially the same size when the body is in the first configuration.
2. The vascular device of clause 1, wherein the apertures are formed by displacement of adjacent strands.
3. The vascular device of clause 1, wherein the plurality of apertures comprises two apertures.
4. The vascular device of clause 2, wherein the apertures are equally spaced and radially arranged around a longitudinal axis of the body.
5. The vascular device of clause 2, wherein a center region of each of the apertures is disposed along a single radial cross section of the body.
6. The vascular device of clause 1, wherein the plurality of apertures comprises three apertures.
7. The vascular device of clause 6, wherein the apertures are equally spaced and radially arranged around a longitudinal axis of the body.
8. The vascular device of clause 6, wherein a center region of each of the apertures is disposed along a single radial cross section of the body.
9. The vascular device of clause 1, wherein the plurality of apertures comprises four apertures. 10. The vascular device of clause 9, wherein the apertures are equally spaced and radially arranged around a longitudinal axis of the body.
11. The vascular device of clause 9, wherein a center region of each of the apertures is disposed along a single radial cross section of the body.
12. The vascular device of clause 1, wherein a number of strands in each of a proximal, center, and distal radial cross sections of the body is the same.
13. The vascular device of clause 1, wherein the body has a hoop strength that is generally uniform along the body's longitudinal length.
14. The vascular device of clause 1, wherein an area of at least one of the apertures is about 0.005 square millimeters or larger.
15. The vascular device of clause 1, wherein an area of at least one of the pores is about 0.01 square millimeters or smaller.
16. The vascular device of clause 1, wherein the apertures are larger than the pores.
17. The vascular device of clause 1, wherein a thickness of each strand is about 0.0010 to 0.0014 inches.
18. A method, for creating a plurality of apertures in a vascular device, comprising:
braiding a plurality of shape-memory strands to form the vascular device, wherein the strands are braided to form a plurality of pores between the strands, wherein the pores at proximal and distal portions of the device are generally uniform in size;
forming each of the apertures by displacing strands disposed at a longitudinal center region of the device with a tapered mandrel, wherein each aperture is larger than a pore; and
applying heat to the displaced strands to thereby set a shape of the displaced strands.
19. The method of clause 18, wherein the plurality of apertures comprises two apertures. 20. The method of clause 18, wherein the plurality of apertures comprises three apertures.
21. The method of clause 18, wherein the plurality of apertures comprises four apertures.
22. The method of clause 18, wherein the apertures are equally spaced and radially arranged around a longitudinal axis of the vascular device.
23. The method of clause 18, wherein a center region of each of the apertures is disposed along a single radial cross section of the vascular device.
24. The method of clause 18, wherein a number of strands in each of a proximal, center, and distal radial cross sections of the vascular device is the same.
25. The method of clause 18, wherein the vascular device has a hoop strength that is generally uniform along the device's longitudinal length.
26. The method of clause 18, wherein the apertures are larger than the pores.
27. A method for providing blood flow into a perforator vessel extending from a sac of an aneurysm, the method comprising:
positioning a vascular device in a vessel at an opening into the aneurysm, wherein the device has a first, collapsed configuration and a second, expanded configuration, the device comprising:
a plurality of heat-set strands, wherein the strands are braided such that when the device is in the second configuration, the strands form a plurality of pores and a plurality of apertures between the strands;
wherein the apertures are disposed at a longitudinal center region of the device;
wherein, when the device is in the second configuration, the pores at proximal and distal portions of the device are generally uniform in size and smaller in size than the apertures; and
wherein the pores and the apertures are substantially the same size when the device is in the first configuration; and aligning the longitudinal center region of the device with the aneurysm to thereby provide blood flow into the perforator through one of the apertures.
28. The method of clause 27, wherein the plurality of apertures comprises two apertures.
29. The method of clause 27, wherein the plurality of apertures comprises three apertures.
30. The method of clause 27, wherein the plurality of apertures comprises four apertures.
31. The method of clause 27, wherein the apertures are equally spaced and radially arranged around a longitudinal axis of the vascular device.
32. The method of clause 27, wherein a center region of each of the apertures is disposed along a single radial cross section of the vascular device.
33. The method of clause 27, wherein a number of strands in each of a proximal, center, and distal radial cross sections of the vascular device are the same.
34. The method of clause 27, wherein the vascular device has a hoop strength that is generally uniform along the device's longitudinal length.
35. The method of clause 27, wherein the apertures are larger than the pores.
[0004] It is understood that other configurations of the subject technology will become readily apparent to those skilled in the art from the following detailed description, wherein various configurations of the subject technology are shown and described by way of illustration. As will be realized, the subject technology is capable of other and different configurations and its several details are capable of modification in various other respects, all without departing from the scope of the subject technology. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not as restrictive.
BRIEF DESCRIPTION OF THE DRAWINGS
[0005] A detailed description will be made with reference to the accompanying drawings: [0006] FIG. 1A depicts a vascular device in a collapsed configuration, according to some embodiments of the subject technology.
[0007] FIG. IB depicts a vascular device in an expanded configuration, according to some embodiments of the subject technology.
[0008] FIG. 1C depicts a detail view of an aperture, according to some embodiments of the subject technology.
[0009] FIG. ID depicts a cross section taken at a longitudinal center of a vascular device, according to some embodiments of the subject technology.
[0010] FIG. IE depicts a cross section taken at a proximal region of a vascular device, according to some embodiments of the subject technology.
[0011] FIG. IF depicts a cross section taken at a distal region of a vascular device, according to some embodiments of the subject technology.
[0012] FIG. 2 depicts a cross section view of a vessel and delivery of a vascular device, according to some embodiments of the subject technology.
[0013] FIG. 3 depicts a cross section view of a vessel and delivery of a vascular device, according to some embodiments of the subject technology.
[0014] FIG. 4 depicts a cross section view of a vessel and delivery of a vascular device, according to some embodiments of the subject technology.
[0015] FIG. 5 depicts a cross section view of a vessel and delivery of a vascular device, according to some embodiments of the subject technology.
[0016] FIG. 6 depicts a cross section view of a vessel and deployed vascular device, according to some embodiments of the subject technology.
DETAILED DESCRIPTION
[0017] Aneurysms may be located, for example, along vessel side walls. A neck of an aneurysm typically defines an opening of between about 2 to 25 mm, though other sizes and ranges are also possible. The neck connects an anatomical vessel lumen to a fundus of the aneurysm. In some instances, "vessel" may refer to blood vessels (including arteries and veins) or other suitable body organs having a lumen, such as the gastrointestinal tract (e.g., esophagus, stomach, small intestine, colon, rectum), bile ducts, urinary bladder, ureter, urethra, trachea, bronchi, and the like. Blood flow within the anatomical lumen is channeled through the neck and into the fundus. In response to the constant blood flow into the fundus of the aneurysm, the wall of the aneurysm continues to distend and presents a significant risk of rupturing. When the blood within the aneurysm causes pressure against the wall of the aneurysm that exceeds the wall strength, the aneurysm ruptures.
[0018] Reduction of blood flow to or within the aneurysm results in a reduction in force against the wall of the aneurysm and a corresponding reduction in the risk of rupturing. Conventionally, a reduction of the force and volume of blood entering the aneurysm may be accomplished by an occluding device. The conventional occluding device restricts blood flow to the aneurysm. The aneurysm, however, may have small perforator vessels or arteries extending from the aneurysm. Because the conventional occluding device isolates the aneurysm from the blood flow in the vessel, any small perforator arteries or vessel branches (both inlet and outlet branches) extending from the aneurysm are also occluded, thereby preventing blood from flowing into the perforator vessels.
[0019] The vascular devices of the subject technology solve some or all of the foregoing problems by sufficiently restricting the blood flow into the aneurysm to prevent rupture while providing sufficient blood flow to perforator vessels or arteries extending from the aneurysm, or extending from the parent vessel sidewall near the aneurysm neck (and/or from a location on the sidewall between the proximal and distal ends of the vascular device when deployed). The vascular device includes an expandable vascular device having one or more enlarged apertures disposed near the neck of the aneurysm. The vascular device is configured to reduce the laminar flow into the aneurysm to prevent rupture, while providing sufficient blood flow to the perforator vessel through one or more of the enlarged apertures. Accordingly, the vascular device exhibits a porosity configured to reduce haemodynamic flow into the aneurysm, but simultaneously allow perfusion to perforator vessels.
[0020] FIGS. 1A-1F depict a vascular device 100, according to some embodiments of the subject technology. The vascular device 100 comprises a body 110 having a first, collapsed configuration and a second, expanded configuration. The body is comprised of a plurality of heat-set strands 112 that are braided such that when the body 110 is in the expanded configuration, the strands 112 form a plurality of pores 120 and a plurality of apertures 130 between the strands 112, as shown in FIG. IB. When the body 110 is in the expanded configuration, the pores 120 at proximal and distal portions of the body 110 are generally uniform in size and smaller in size than the apertures 130. Referring to FIG. 1A, when the body 110 is in the collapsed configuration, the pores 120 and the apertures 130 are substantially the same size. [0021] The body 110 may be a self-expanding stent made of two or more round or ovoid wire strands or filaments 112. In one aspect, the filaments may all be of the same thickness. For example, the thickness of each strand 112 may be about 0.0001 to 0.0020 inches. The filaments may be formed of known flexible and shape memory materials, such as nitinol, platinum and stainless steel. The body 110 may be fabricated from platinum/8% tungsten and 35N LT (cobalt nickel alloy, which is a low titanium version of MP35N alloy) alloy wires. In other embodiments, one or more of the filaments can be formed of a biocompatible metal material or a biocompatible polymer, so long as the filaments are flexible and have shape memory properties. The filaments may be braided into a resulting lattice-like structure. In at least one embodiment, during braiding or winding of the body 110, the filaments may be loosely braided using a 1-over- 2-under-2 system. In other embodiments, however, other methods of braiding may be followed, without departing from the scope of the disclosure.
[0022] The ends of the body 110 may be cut to length and therefore remain free for radial expansion and contraction. The body 110 may exhibit a high degree of flexibility due to the materials used, the porosity of the body 110, and the fact that the ends of the filaments are not secured to each other.
[0023] The pores 120 at the proximal and distal portions of the body 110 are sized to reduce haemodynamic flow into an aneurysm and the apertures 130 are sized to provide sufficient blood flow to any perforator vessels extending from the aneurysm. For example, an area of at least one of the pores 120 may be about 0.01 square millimeters or less and an area of at least one of the apertures 130 may be about 0.005 square millimeters or more. In some aspects, the apertures 130 are larger than the pores 120. In some embodiments, the apertures 130 are configured to be about five times the size of the pores 120. In some embodiments, the apertures 130 are sized to be range from about two to about ten times the size of the pores 120, while in some embodiments, the apertures 130 are sized to range from about three to about seven times the size of the pores 120.
[0024] The apertures 130 may be disposed at a longitudinal center region of the body 110 and be formed by displacement of adjacent strands, as shown in FIG. 1C. In one aspect, the vascular device 100 may have two apertures 130 disposed at the longitudinal center region of the body 110. In another example, the vascular device 100 may have three apertures 130 disposed at the longitudinal center region of the body 110. In yet another example, the vascular device 100 may have four apertures 130 disposed at the longitudinal center region of the body 110. Although FIGS. 1A-D depict four apertures 130, it is understood that a number of apertures greater than four may be suitable for many applications. The apertures 130 may be equally spaced and radially arranged around a longitudinal axis 140 of the body. In some aspects, a center region 132 of each of the apertures 130 is disposed along a single radial cross section of the body 110, as shown in FIG. ID.
[0025] In some aspects, because the pores 120 and the apertures 130 generally comprise gaps, voids, or areas that are formed between adjacent strands 112, the number of strands 112 in each of a proximal, center, and distal radial cross sections of the body 1 10 is the same. For example, referring to FIGS. ID- IF, the number of strands 112 shown at the proximal cross section of the body 110, shown in FIG. IE, is the same as the number of strands 112 shown at the center cross section of the body 110, shown in FIG. ID, and the distal cross section of the body 110, shown in FIG. IF. Because the number of strands 112 at each of the proximal, center, and distal radial cross sections of the body 110 is the same, the body 110 has a hoop strength that is generally uniform along the body's 110 longitudinal length.
[0026] In one aspect, the apertures 130 may be formed on the vascular device 100 by first placing the vascular device 100 in the expanded configuration on a fixture and then inserting one or more tapered mandrels, depending on the number of apertures 130, through the body 110 to displace the strands 112 and thereby form the apertures 130. The displaced strands 112 are then heated to their shape memory temperature to "set" the displaced strands in their displaced configuration. Thereafter, the one or more mandrels are removed from the body 110 and the apertures 130 remain formed on the body 110.
[0027] When the vascular device 100 is in the collapsed configuration, the displaced strands 112 forming the apertures 130 are collapsed, along with all the strands 112 comprising the body 110, and the apertures 130 and the pores 120 are substantially the same size, as shown in FIG. 1 A.
[0028] In one aspect, the vascular device may be coated with an endothelial progenitor cell coating to promote endothelium growth on an inner surface of the vascular device 100. Typically, the endothelium will grow from the proximal and/or distal ends of the vascular device 100 and traverse toward the longitudinal center of the vascular device 100. The strands 112 of the vascular device 100 serve as a substrate for the cells to attach thereto. As the inner surface of the vascular device becomes endothelialized, the pores 120 are occluded. Because the apertures 130 are larger than the pores 120, the endothelium grows around the apertures 130 but does not occlude the apertures 130. Accordingly, the apertures 130 remain unobstructed and permit blood to flow therethrough to feed any perforator vessel emanating from an aneurysm fundus, or emanating from the parent vessel sidewall near the aneurysm neck (and/or from a location on the sidewall between the proximal and distal ends of the vascular device when deployed).
[0029] Radiopaque markers may be located adjacent the proximal or distal portions of the vascular device 100, and may be located at any position along the length of the vascular device 100 between a proximal and distal end of the vascular device 100. The markers may be attached to the vascular device 100 by techniques such as adhesives, heat fusion, interference fit, fasteners, intermediate members, coatings, or by other techniques.
[0030] In some embodiments, the markers are comprised of ultrasonic markers, MRI-safe markers, or other markers. In some embodiments ultrasonic markers permit a physician to accurately determine the position of the vascular device 100 within a patient under ultrasonic visualization. Materials for an ultrasonic marker have an acoustical density sufficiently different from the vascular device 100 to provide suitable visualization via ultrasonic techniques. Exemplary materials comprise polymers, metals such as tantalum, platinum, gold, tungsten and alloys of such metals, hollow glass spheres or microspheres, and other materials.
[0031] In some embodiments, MRI-safe markers permit a physician to accurately determine the position of the vascular device 100 within a patient under magnetic resonance imaging. Exemplary materials for making MRI-safe marker have a magnetic signature sufficiently different from the vascular device 100 to provide suitable visualization via MRI techniques. Exemplary materials comprise polymers, metals such as tantalum, platinum, gold, tungsten and alloys of such metals, non-ferrous materials, and other materials.
[0032] A technique for treating an aneurysm and providing blood flow into a perforator vessel extending from a sac of the aneurysm will now be discussed with reference to FIGS. 2-5. The vascular device 100 may be delivered to a treatment site using a delivery system 200. The delivery system 200 may include a catheter, which may for example, be an over the wire (OTW) catheter, a rapid exchange (multiple lumen) catheter, or a fixed wire catheter.
[0033] Prior to delivery, an outer sheath 210 is disposed over the vascular device 100 to confine the vascular device 100 in the first, collapsed configuration. The vascular device 100 is cooperatively movable within the outer sheath 210 in order to deliver the vascular device 100 to a treatment site, such as an aneurysm 310, within the vasculature 300 of a patient. [0034] The outer sheath 210 may be configured to be introduced and advanced through the vasculature of the patient. The outer sheath 210 may be made from various thermoplastics, e.g., PTFE, FEP, HDPE, PEEK, etc., which may optionally be lined on the inner surface of the outer sheath 140 or an adjacent surface with a hydrophilic material such as PVP or some other plastic coating. Additionally, either surface may be coated with various combinations of different materials, depending upon the desired results.
[0035] The delivery system 200 also includes a shaft 220 and a guide wire 230. The shaft 220 has a guide wire lumen for allowing the guide wire 230 to extend therethrough. The shaft 220 may also include a reduced diameter at a distal region to provide sufficient annular space in which the vascular device 100 may be stowed.
[0036] Radiopaque markers may be provided at various locations along the length of the delivery system 200. For example, an enlarged distal tip 240 of the shaft 220 may be radiopaque. In another example, radiopaque markers may be provided on the reduced diameter distal region of the shaft 220, beneath the distal and proximal end of the vascular device 100. In yet another example, a radiopaque marker 250 may be disposed on the shaft 220 adjacent to a longitudinal center of the vascular device 100, corresponding to the location of the apertures 130.
[0037] In one aspect, the vascular device 100 may be configured with differently sized apertures 130 and/or number of apertures 130. A physician may therefore select the appropriate vascular device 100 based on a size of the aneurysm and/or a number of perforators extending from the aneurysm and the diameter of each aperture 130 and/or number of apertures 130 per vascular device 100. For example, based on the diameter of each aperture 130 and the number of perforators extending from the aneurysm sac and/or from the parent vessel 300, the vascular device 100 may be selected such that the apertures 130 in fluid communication with the sac (and/or with other relevant vessel location(s)) are sufficiently large to provide sufficient blood flow to each of the perforators when the vascular device 100 is in the second, expanded configuration. The blood flow permitted by the apertures 130 to the perforators is sufficient to provide blood to downstream tissues without inducing ischemia.
[0038] In another example, based on the number of apertures 130 in the vascular device 100 and the number of perforators extending from the aneurysm sac and/or from the parent vessel 300, the vascular device 100 may be selected such that there are a sufficient number of apertures 130 in fluid communication with the sac (and/or with other relevant vessel location(s)) to provide sufficient blood flow to each of the perforators when the vascular device 100 is in the second, expanded configuration. In these applications, sufficient blood flow is provided for the perforators extending from the aneurysm sac and/or parent vessel 300 to avoid or limit ischemia to downstream tissue, but the blood flow within the aneurysm is disrupted sufficiently to permit healing of the aneurysm.
[0039] Referring to FIG. 2, the delivery system 200 is advanced percutaneously over the guide wire 230, in this example, to the site of the aneurysm 310 having a perforator vessel 320 extending therefrom.
[0040] Referring to FIG. 3, after navigating the system 200 to the treatment site within the patient, the outer sheath 210 is withdrawn proximally while maintaining the position of the shaft 220 to thereby expose a distal portion of the shaft 220 and the vascular device 100. The outer sheath 210 is withdrawn until a distal end of the outer sheath 210 is proximal of the vascular device 100. As the outer sheath 210 is withdrawn, the vascular device 100 expands. During expansion, the apertures 130 may begin to take form due to the shape memory properties of the strands 112.
[0041] Referring to FIGS. 4 and 5, the delivery system 200 may be adjusted or withdrawn proximally during deployment, until the radiopaque marker 250 and hence the apertures 130 are centered along the length of the ostium or neck of the aneurysm 310 and/or located on either side of the ostium, as appropriate. In other words, the longitudinal center region of the vascular device 100, the region having the apertures 130, is aligned with the aneurysm 310 to thereby provide blood flow into the perforator 320 through one of the apertures 130. In one aspect, the longitudinal center region of the vascular device 100 is centered along the length of the ostium so that at least one aperture 130 provides blood flow to the perforator 320 when the vascular device 110 is in the second, expanded configuration.
[0042] In one aspect, during deployment, the position of the vascular device 100 within the vessel 300 may be further modified, if after initial partial deployment of the vascular device 100, the vascular device is positioned incorrectly or otherwise has to be relocated to properly cover the treatment site. For example, the outer sheath 210 may be advanced distally, thereby encapsulating or compressing the vascular device 100 within the outer sheath 210 and allowing the system 200 to be repositioned. Accordingly, the vascular device 100 may be partially deployed, resheathed, and relocated multiple times in order to ensure that the vascular device is properly deployed in the correct location. [0043] In another aspect, because of the woven or braided structure of the vascular device 100, the strands of the vascular device 100 can also move relative to each other, further allowing the vascular device 100 to flex and thereby permit advancement or rotation of the unexpanded portion of the vascular device 100 against an expanded portion of the vascular device 100 that is deployed within the vessel 300. Accordingly, through rotation or positioning of the unexpanded portion relative to the expanded portion of the vascular device 100, the apertures 130 of the vascular device 100 may be properly aligned and positioned at the treatment site.
[0044] Referring to FIG. 6, once the entire vascular device 100 is fully expanded, the catheter, along with the outer sheath 210, shaft 220, and guide wire 230 may be withdrawn from the patient.
[0045] Initially, blood may flow to the perforator vessel 320 from the plurality of pores 120 and apertures 130. As the inner surface of the vascular device 100 becomes endothelialized, the pores 120 will become occluded thereby preventing blood from flowing therethrough. The blood, however, will continue to flow through the apertures 130, thereby providing sufficient blood flow to the perforator 320.
[0046] In one arrangement, the vascular device 100 may be comprised of metal, polymer, ceramic, permanent enduring materials, and may comprise either or both of non-bioabsorbable and bioabsorbable materials. Exemplary materials include, but are not limited to, NITINOL®, stainless steel, cobalt chromium alloys, Elgiloy, magnesium alloys, polylactic acid, poly glycolic acid, poly ester amide (PEA), poly ester urethane (PEU), amino acid based bioanalogous polymers, tungsten, tantalum, platinum, polymers, bio-polymers, ceramics, bio-ceramics, or metallic glasses. Part or all of the medical device may elute over time substances such as drugs, biologies, gene therapies, antithrombotics, coagulants, anti-inflammatory drugs, immunomodulator drugs, anti-proliferatives, migration inhibitors, extracellular matrix modulators, healing promoters, re-endothelialization promoters, or other materials. In some embodiments, the vascular device 100 may be formed from materials having shape memory properties. In some embodiments, the vascular device 100 may be finished by processes to remove slag. In some embodiments, the vascular device 100 may be subjected to a tempering treatment at temperatures customarily applied to the material so that the impressed structure is permanently established.
[0047] The vascular device 100 may have various lengths and diameters. For example, the vascular device 100 may have specific cross-sectional diameters, the diameters being measured when the vascular device 110 is fully free to expand, ranging from about 2 mm to about 6 mm. If the vascular device 110 has a diameter between about 3 mm and about 4 mm, it may be used in a size 18 microcatheters (i.e., microcatheters with an inner diameter of approximately 0.21 inch). If the vascular device 100 has a diameter between about 5 mm and about 6 mm, it may be used in a size 27 microcatheters (i.e., microcatheters with an inner diameter of approximately 0.027 inch). However, other suitable cross-sectional diameters may be used without deviating from the scope of the subject technology. In some embodiments, the vascular device 100 may have lengths, measured proximally to distally along the longitudinal axis of the vascular device 100, ranging from about 15 mm to about 40 mm, though other ranges and sizes are also possible.
[0048] The detailed description set forth above is intended as a description of various configurations of the subject technology and is not intended to represent the only configurations in which the subject technology may be practiced. The appended drawings are incorporated herein and constitute a part of the detailed description. The detailed description includes specific details for the purpose of providing a thorough understanding of the subject technology. However, it will be apparent to those skilled in the art that the subject technology may be practiced without these specific details. In some instances, well-known structures and components are shown in block diagram form in order to avoid obscuring the concepts of the subject technology.
[0049] Skilled artisans may implement the described functionality in varying ways for each particular application. Various components and blocks may be arranged differently (for example, arranged in a different order, or partitioned in a different way) all without departing from the scope of the subject technology. It is understood that the specific order or hierarchy of steps in the processes disclosed is an illustration of exemplary approaches. Based upon design preferences, it is understood that the specific order or hierarchy of steps in the processes may be rearranged. Some of the steps may be performed simultaneously. The accompanying method claims present elements of the various steps in a sample order, and are not meant to be limited to the specific order or hierarchy presented.
[0050] The previous description is provided to enable any person skilled in the art to practice the various aspects described herein. The previous description provides various examples of the subject technology, and the subject technology is not limited to these examples. Various modifications to these aspects will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other aspects. Thus, the claims are not intended to be limited to the aspects shown herein, but is to be accorded the full scope consistent with the language claims, wherein reference to an element in the singular is not intended to mean "one and only one" unless specifically so stated, but rather "one or more." Unless specifically stated otherwise, the term "some" refers to one or more. Pronouns in the masculine (for example, his) include the feminine and neuter gender (for example, her and its) and vice versa. Headings and subheadings, if any, are used for convenience only and do not limit the invention.
[0051] A phrase such as an "aspect" does not imply that such aspect is essential to the subject technology or that such aspect applies to all configurations of the subject technology. A disclosure relating to an aspect may apply to all configurations, or one or more configurations. An aspect may provide one or more examples. A phrase such as an aspect may refer to one or more aspects and vice versa. A phrase such as an "aspect" does not imply that such aspect is essential to the subject technology or that such aspect applies to all configurations of the subject technology. A disclosure relating to an aspect may apply to all aspects, or one or more aspects. An aspect may provide one or more examples. A phrase such as an "aspect" may refer to one or more aspects and vice versa. A phrase such as a "configuration" does not imply that such configuration is essential to the subject technology or that such configuration applies to all configurations of the subject technology. A disclosure relating to a configuration may apply to all configurations, or one or more configurations. A configuration may provide one or more examples. A phrase such as a "configuration" may refer to one or more configurations and vice versa.
[0052] The word "exemplary" is used herein to mean "serving as an example or illustration." Any aspect or design described herein as "exemplary" is not necessarily to be construed as preferred or advantageous over other aspects or designs.
[0053] All structural and functional equivalents to the elements of the various aspects described throughout this disclosure that are known or later come to be known to those of ordinary skill in the art are expressly incorporated herein by reference and are intended to be encompassed by the claims. Moreover, nothing disclosed herein is intended to be dedicated to the public regardless of whether such disclosure is explicitly recited in the claims. No claim element is to be construed under the provisions of 35 U.S.C. § 112, sixth paragraph, unless the element is expressly recited using the phrase "means for" or, in the case of a method claim, the element is recited using the phrase "step for." Furthermore, to the extent that the term "include," "have," or the like is used in the description or the claims, such term is intended to be inclusive in a manner similar to the term "comprise" as "comprise" is interpreted when employed as a transitional word in a claim.

Claims

CLAIMS WHAT IS CLAIMED IS:
1. A vascular device, comprising:
a body having a first, collapsed configuration and a second, expanded configuration, the body comprised of a plurality of heat-set strands;
wherein the strands are braided such that when the body is in the second configuration, the strands form a plurality of pores and a plurality of apertures between the strands;
wherein the apertures are disposed at a longitudinal center region of the body;
wherein, when the body is in the second configuration, the pores at proximal and distal portions of the body are generally uniform in size and smaller in size than the apertures; and
wherein the pores and the apertures are substantially the same size when the body is in the first configuration.
2. The vascular device of claim 1, wherein the apertures are formed by displacement of adjacent strands.
3. The vascular device of claim 1, wherein the plurality of apertures comprises two apertures.
4. The vascular device of claim 2, wherein the apertures are equally spaced and radially arranged around a longitudinal axis of the body.
5. The vascular device of claim 2, wherein a center region of each of the apertures is disposed along a single radial cross section of the body.
6. The vascular device of claim 1, wherein the plurality of apertures comprises three apertures.
7. The vascular device of claim 6, wherein the apertures are equally spaced and radially arranged around a longitudinal axis of the body.
8. The vascular device of claim 6, wherein a center region of each of the apertures is disposed along a single radial cross section of the body.
9. The vascular device of claim 1, wherein the plurality of apertures comprises four apertures.
10. The vascular device of claim 9, wherein the apertures are equally spaced and radially arranged around a longitudinal axis of the body.
11. The vascular device of claim 9, wherein a center region of each of the apertures is disposed along a single radial cross section of the body.
12. The vascular device of claim 1, wherein a number of strands in each of a proximal, center, and distal radial cross sections of the body is the same.
13. The vascular device of claim 1, wherein the body has a hoop strength that is generally uniform along the body's longitudinal length.
14. The vascular device of claim 1, wherein an area of at least one of the apertures is about 0.005 square millimeters or larger.
15. The vascular device of claim 1, wherein an area of at least one of the pores is about 0.01 square millimeters or smaller.
16. The vascular device of claim 1, wherein the apertures are larger than the pores.
17. The vascular device of claim 1, wherein a thickness of each strand is about 0.0010 to 0.0014 inches.
18. A method, for creating a plurality of apertures in a vascular device, comprising:
braiding a plurality of shape-memory strands to form the vascular device, wherein the strands are braided to form a plurality of pores between the strands, wherein the pores at proximal and distal portions of the device are generally uniform in size; forming each of the apertures by displacing strands disposed at a longitudinal center region of the device with a tapered mandrel, wherein each aperture is larger than a pore; and
applying heat to the displaced strands to thereby set a shape of the displaced strands.
19. The method of claim 18, wherein the plurality of apertures comprises two apertures.
20. The method of claim 18, wherein the plurality of apertures comprises three apertures.
21. The method of claim 18, wherein the plurality of apertures comprises four apertures.
22. The method of claim 18, wherein the apertures are equally spaced and radially arranged around a longitudinal axis of the vascular device.
23. The method of claim 18, wherein a center region of each of the apertures is disposed along a single radial cross section of the vascular device.
24. The method of claim 18, wherein a number of strands in each of a proximal, center, and distal radial cross sections of the vascular device is the same.
25. The method of claim 18, wherein the vascular device has a hoop strength that is generally uniform along the device's longitudinal length.
26. The method of claim 18, wherein the apertures are larger than the pores.
27. A method for providing blood flow into a perforator vessel extending from a sac of an aneurysm, the method comprising:
positioning a vascular device in a vessel at an opening into the aneurysm, wherein the device has a first, collapsed configuration and a second, expanded configuration, the device comprising: a plurality of heat-set strands, wherein the strands are braided such that when the device is in the second configuration, the strands form a plurality of pores and a plurality of apertures between the strands;
wherein the apertures are disposed at a longitudinal center region of the device;
wherein, when the device is in the second configuration, the pores at proximal and distal portions of the device are generally uniform in size and smaller in size than the apertures; and
wherein the pores and the apertures are substantially the same size when the device is in the first configuration; and
aligning the longitudinal center region of the device with the aneurysm to thereby provide blood flow into the perforator through one of the apertures.
28. The method of claim 27, wherein the plurality of apertures comprises two apertures.
29. The method of claim 27, wherein the plurality of apertures comprises three apertures.
30. The method of claim 27, wherein the plurality of apertures comprises four apertures.
31. The method of claim 27, wherein the apertures are equally spaced and radially arranged around a longitudinal axis of the vascular device.
32. The method of claim 27, wherein a center region of each of the apertures is disposed along a single radial cross section of the vascular device.
33. The method of claim 27, wherein a number of strands in each of a proximal, center, and distal radial cross sections of the vascular device are the same.
34. The method of claim 27, wherein the vascular device has a hoop strength that is generally uniform along the device's longitudinal length.
35. The method of claim 27, wherein the apertures are larger than the pores.
PCT/US2014/011198 2013-02-05 2014-01-13 Vascular device aneurysm treatment and providing blood flow into a perforator vessel WO2014123659A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP14703465.6A EP2953552B1 (en) 2013-02-05 2014-01-13 Vascular device for aneurysm treatment and providing blood flow into a perforator vessel

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361760907P 2013-02-05 2013-02-05
US61/760,907 2013-02-05
US13/826,147 2013-03-14
US13/826,147 US9157174B2 (en) 2013-02-05 2013-03-14 Vascular device for aneurysm treatment and providing blood flow into a perforator vessel

Publications (1)

Publication Number Publication Date
WO2014123659A1 true WO2014123659A1 (en) 2014-08-14

Family

ID=51259915

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/011198 WO2014123659A1 (en) 2013-02-05 2014-01-13 Vascular device aneurysm treatment and providing blood flow into a perforator vessel

Country Status (3)

Country Link
US (2) US9157174B2 (en)
EP (1) EP2953552B1 (en)
WO (1) WO2014123659A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005247490B2 (en) 2004-05-25 2011-05-19 Covidien Lp Flexible vascular occluding device
US8628564B2 (en) 2004-05-25 2014-01-14 Covidien Lp Methods and apparatus for luminal stenting
KR101300437B1 (en) 2004-05-25 2013-08-26 코비디엔 엘피 Vascular stenting for aneurysms
US8152833B2 (en) 2006-02-22 2012-04-10 Tyco Healthcare Group Lp Embolic protection systems having radiopaque filter mesh
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
US11484322B2 (en) 2018-01-03 2022-11-01 Aneuclose Llc Aneurysm neck bridge with a closeable opening or lumen through which embolic material is inserted into the aneurysm sac
US11471163B2 (en) 2008-05-01 2022-10-18 Aneuclose Llc Intrasaccular aneurysm occlusion device with net or mesh expanded by string-of-pearls embolies
US11464518B2 (en) 2008-05-01 2022-10-11 Aneuclose Llc Proximal concave neck bridge with central lumen and distal net for occluding cerebral aneurysms
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
CA3082787C (en) 2011-12-06 2021-03-09 Aortic Innovations Llc Device for endovascular aortic repair and method of using the same
US9301831B2 (en) 2012-10-30 2016-04-05 Covidien Lp Methods for attaining a predetermined porosity of a vascular device
US9452070B2 (en) 2012-10-31 2016-09-27 Covidien Lp Methods and systems for increasing a density of a region of a vascular device
US9943427B2 (en) 2012-11-06 2018-04-17 Covidien Lp Shaped occluding devices and methods of using the same
US9157174B2 (en) 2013-02-05 2015-10-13 Covidien Lp Vascular device for aneurysm treatment and providing blood flow into a perforator vessel
US10433852B2 (en) 2017-05-08 2019-10-08 William Z. H'Doubler Aortic occlusion balloon apparatus, system and method of making
US20210128183A1 (en) * 2019-10-31 2021-05-06 Neuravi Limited Thrombectomy and stenting system

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998047447A1 (en) * 1997-04-23 1998-10-29 Dubrul William R Bifurcated stent and distal protection system
WO2006034140A2 (en) * 2004-09-17 2006-03-30 Cordis Neurovascular, Inc. Thin film devices for temporary or permanent occlusion of a vessel
US20070208415A1 (en) * 2006-03-06 2007-09-06 Kevin Grotheim Bifurcated stent with controlled drug delivery
WO2008005898A2 (en) * 2006-06-30 2008-01-10 Ev3 Endovascular, Inc. Medical devices with amorphous metals and methods therefor
US20100318174A1 (en) * 1998-12-11 2010-12-16 Endologix, Inc. Implantable vascular graft
US20120290067A1 (en) * 2011-05-11 2012-11-15 Tyco Healthcare Group Lp Vascular remodeling device

Family Cites Families (513)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2919467A (en) 1955-11-09 1960-01-05 Plastic Textile Access Ltd Production of net-like structures
US5876419A (en) 1976-10-02 1999-03-02 Navius Corporation Stent and method for making a stent
JPS6037735B2 (en) 1978-10-18 1985-08-28 住友電気工業株式会社 Artificial blood vessel
SE445884B (en) 1982-04-30 1986-07-28 Medinvent Sa DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION
US4512338A (en) 1983-01-25 1985-04-23 Balko Alexander B Process for restoring patency to body vessels
US4503569A (en) 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
US4538622A (en) 1983-11-10 1985-09-03 Advanced Cardiovascular Systems, Inc. Guide wire for catheters
US4572186A (en) 1983-12-07 1986-02-25 Cordis Corporation Vessel dilation
FR2556210B1 (en) 1983-12-08 1988-04-15 Barra Jean Aubert VENOUS PROSTHESIS AND PROCESS FOR PRODUCING THE SAME
US7166125B1 (en) 1988-03-09 2007-01-23 Endovascular Technologies, Inc. Intraluminal grafting system
US5669936A (en) 1983-12-09 1997-09-23 Endovascular Technologies, Inc. Endovascular grafting system and method for use therewith
US5749920A (en) 1983-12-09 1998-05-12 Endovascular Technologies, Inc. Multicapsule intraluminal grafting system and method
US6221102B1 (en) 1983-12-09 2001-04-24 Endovascular Technologies, Inc. Intraluminal grafting system
US4580568A (en) 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US4733665C2 (en) 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4681110A (en) 1985-12-02 1987-07-21 Wiktor Dominik M Catheter arrangement having a blood vessel liner, and method of using it
EP0556940A1 (en) 1986-02-24 1993-08-25 Robert E. Fischell Intravascular stent
SE453258B (en) 1986-04-21 1988-01-25 Medinvent Sa ELASTIC, SELF-EXPANDING PROTEST AND PROCEDURE FOR ITS MANUFACTURING
WO1988000813A1 (en) 1986-08-05 1988-02-11 St. Jude Medical, Inc. Braided polyester vascular prosthesis and method
US5041126A (en) 1987-03-13 1991-08-20 Cook Incorporated Endovascular stent and delivery system
US5011488A (en) 1988-12-07 1991-04-30 Robert Ginsburg Thrombus extraction system
US4856516A (en) 1989-01-09 1989-08-15 Cordis Corporation Endovascular stent apparatus and method
US5180368A (en) 1989-09-08 1993-01-19 Advanced Cardiovascular Systems, Inc. Rapidly exchangeable and expandable cage catheter for repairing damaged blood vessels
US5035706A (en) 1989-10-17 1991-07-30 Cook Incorporated Percutaneous stent and method for retrieval thereof
US5108416A (en) 1990-02-13 1992-04-28 C. R. Bard, Inc. Stent introducer system
US5545208A (en) 1990-02-28 1996-08-13 Medtronic, Inc. Intralumenal drug eluting prosthesis
IL94138A (en) 1990-04-19 1997-03-18 Instent Inc Device for the treatment of constricted fluid conducting ducts
US5344426A (en) 1990-04-25 1994-09-06 Advanced Cardiovascular Systems, Inc. Method and system for stent delivery
US5242399A (en) 1990-04-25 1993-09-07 Advanced Cardiovascular Systems, Inc. Method and system for stent delivery
US5360443A (en) 1990-06-11 1994-11-01 Barone Hector D Aortic graft for repairing an abdominal aortic aneurysm
US5449372A (en) 1990-10-09 1995-09-12 Scimed Lifesystems, Inc. Temporary stent and methods for use and manufacture
JPH0717314Y2 (en) 1990-10-18 1995-04-26 ソン ホーヨン Self-expanding intravascular stent
US5160341A (en) 1990-11-08 1992-11-03 Advanced Surgical Intervention, Inc. Resorbable urethral stent and apparatus for its insertion
US5246420A (en) 1990-11-19 1993-09-21 Danforth Biomedical Incorporated Highly steerable dilatation balloon catheter system
CA2060067A1 (en) 1991-01-28 1992-07-29 Lilip Lau Stent delivery system
DE69229312T2 (en) 1991-03-29 1999-11-04 Vascular Graft Research Center ARTIFICIAL BLOOD VESSEL FROM COMPOSITE MATERIAL
US5628783A (en) 1991-04-11 1997-05-13 Endovascular Technologies, Inc. Bifurcated multicapsule intraluminal grafting system and method
US6682557B1 (en) 1991-04-11 2004-01-27 Endovascular Technologies, Inc. Bifurcated multicapsule intraluminal grafting system and method
CA2202800A1 (en) 1991-04-11 1992-10-12 Alec A. Piplani Endovascular graft having bifurcation and apparatus and method for deploying the same
US5197978B1 (en) 1991-04-26 1996-05-28 Advanced Coronary Tech Removable heat-recoverable tissue supporting device
US5876445A (en) 1991-10-09 1999-03-02 Boston Scientific Corporation Medical stents for body lumens exhibiting peristaltic motion
US5366504A (en) 1992-05-20 1994-11-22 Boston Scientific Corporation Tubular medical prosthesis
US5209731A (en) 1991-12-13 1993-05-11 Endovascular Technologies, Inc. Hand-held gun for inflating and aspirating large volume balloons
US5192297A (en) 1991-12-31 1993-03-09 Medtronic, Inc. Apparatus and method for placement and implantation of a stent
US5507767A (en) 1992-01-15 1996-04-16 Cook Incorporated Spiral stent
ATE135900T1 (en) 1992-02-03 1996-04-15 Schneider Europ Ag CATHETER WITH A VESSEL SUPPORT
US5405377A (en) 1992-02-21 1995-04-11 Endotech Ltd. Intraluminal stent
US7101392B2 (en) 1992-03-31 2006-09-05 Boston Scientific Corporation Tubular medical endoprostheses
JPH07505316A (en) 1992-03-31 1995-06-15 ボストン サイエンティフィック コーポレーション medical wire
US5201757A (en) 1992-04-03 1993-04-13 Schneider (Usa) Inc. Medial region deployment of radially self-expanding stents
US5368566A (en) 1992-04-29 1994-11-29 Cardiovascular Dynamics, Inc. Delivery and temporary stent catheter having a reinforced perfusion lumen
US5540712A (en) 1992-05-01 1996-07-30 Nitinol Medical Technologies, Inc. Stent and method and apparatus for forming and delivering the same
US5817102A (en) 1992-05-08 1998-10-06 Schneider (Usa) Inc. Apparatus for delivering and deploying a stent
JP2660101B2 (en) 1992-05-08 1997-10-08 シュナイダー・(ユーエスエイ)・インコーポレーテッド Esophageal stent and delivery device
US5342387A (en) 1992-06-18 1994-08-30 American Biomed, Inc. Artificial support for a blood vessel
US6336938B1 (en) 1992-08-06 2002-01-08 William Cook Europe A/S Implantable self expanding prosthetic device
US5562725A (en) 1992-09-14 1996-10-08 Meadox Medicals Inc. Radially self-expanding implantable intraluminal device
ATE149325T1 (en) 1992-10-12 1997-03-15 Schneider Europ Ag CATHETER WITH A VESSEL SUPPORT
US5382259A (en) 1992-10-26 1995-01-17 Target Therapeutics, Inc. Vasoocclusion coil with attached tubular woven or braided fibrous covering
DE59206251D1 (en) 1992-10-31 1996-06-13 Schneider Europ Ag Arrangement for implanting self-expanding endoprostheses
US5836868A (en) 1992-11-13 1998-11-17 Scimed Life Systems, Inc. Expandable intravascular occlusion material removal devices and methods of use
ATE111716T1 (en) 1992-12-16 1994-10-15 Schneider Europ Ag DEVICE FOR IMPLANTING A SELF-EXPANDING ENTHOPROSTHESIS.
EP0676936A1 (en) 1992-12-30 1995-10-18 Schneider (Usa) Inc. Apparatus for deploying body implantable stents
US5599291A (en) 1993-01-04 1997-02-04 Menlo Care, Inc. Softening expanding ureteral stent
US5423849A (en) 1993-01-15 1995-06-13 Target Therapeutics, Inc. Vasoocclusion device containing radiopaque fibers
CA2152594C (en) 1993-01-19 1998-12-01 David W. Mayer Clad composite stent
US20050059889A1 (en) 1996-10-16 2005-03-17 Schneider (Usa) Inc., A Minnesota Corporation Clad composite stent
SG85682A1 (en) 1993-03-11 2002-01-15 Medinol Ltd Stent
US5415637A (en) 1993-04-14 1995-05-16 Advanced Cardiovascular Systems, Inc. Temporary stenting catheter with drug delivery capabilities
US5401257A (en) 1993-04-27 1995-03-28 Boston Scientific Corporation Ureteral stents, drainage tubes and the like
US5480423A (en) 1993-05-20 1996-01-02 Boston Scientific Corporation Prosthesis delivery
IL105828A (en) 1993-05-28 1999-06-20 Medinol Ltd Medical stent
EP0627201B1 (en) 1993-06-02 1998-07-22 Schneider (Europe) GmbH Device for releasing a self-expanding endoprosthesis
US5458615A (en) 1993-07-06 1995-10-17 Advanced Cardiovascular Systems, Inc. Stent delivery system
US5464449A (en) 1993-07-08 1995-11-07 Thomas J. Fogarty Internal graft prosthesis and delivery system
EP0662806B1 (en) 1993-07-23 2001-04-11 Cook Incorporated A flexible stent having a pattern formed from a sheet of material
CA2125258C (en) 1993-08-05 1998-12-22 Dinah B Quiachon Multicapsule intraluminal grafting system and method
US6025044A (en) 1993-08-18 2000-02-15 W. L. Gore & Associates, Inc. Thin-wall polytetrafluoroethylene tube
WO1995009586A1 (en) 1993-10-01 1995-04-13 Emory University Self-expanding intraluminal composite prosthesis
US5632772A (en) 1993-10-21 1997-05-27 Corvita Corporation Expandable supportive branched endoluminal grafts
US5639278A (en) 1993-10-21 1997-06-17 Corvita Corporation Expandable supportive bifurcated endoluminal grafts
US5476505A (en) 1993-11-18 1995-12-19 Advanced Cardiovascular Systems, Inc. Coiled stent and delivery system
IN182507B (en) 1993-11-23 1999-04-24 Commw Scient Ind Res Org
RU2089131C1 (en) 1993-12-28 1997-09-10 Сергей Апполонович Пульнев Stent-expander
US6165213A (en) 1994-02-09 2000-12-26 Boston Scientific Technology, Inc. System and method for assembling an endoluminal prosthesis
IL108832A (en) 1994-03-03 1999-12-31 Medinol Ltd Urological stent and deployment device therefor
US6165210A (en) 1994-04-01 2000-12-26 Gore Enterprise Holdings, Inc. Self-expandable helical intravascular stent and stent-graft
US5824044A (en) 1994-05-12 1998-10-20 Endovascular Technologies, Inc. Bifurcated multicapsule intraluminal grafting system
EP0759730B1 (en) 1994-05-19 1999-02-10 Scimed Life Systems, Inc. Improved tissue supporting devices
DK63894A (en) 1994-06-06 1996-01-08 Meadox Medicals Inc Stent catheter and method for making such a stent catheter
US5683451A (en) 1994-06-08 1997-11-04 Cardiovascular Concepts, Inc. Apparatus and methods for deployment release of intraluminal prostheses
US5824041A (en) 1994-06-08 1998-10-20 Medtronic, Inc. Apparatus and methods for placement and repositioning of intraluminal prostheses
US6123715A (en) 1994-07-08 2000-09-26 Amplatz; Curtis Method of forming medical devices; intravascular occlusion devices
US5636641A (en) 1994-07-25 1997-06-10 Advanced Cardiovascular Systems, Inc. High strength member for intracorporeal use
US5891108A (en) 1994-09-12 1999-04-06 Cordis Corporation Drug delivery stent
EP1181904B1 (en) 1994-10-17 2009-06-24 Kabushikikaisha Igaki Iryo Sekkei Stent for liberating drug
EP0788332B1 (en) 1994-10-27 2000-11-08 Boston Scientific Limited Stent delivery device
CA2175720C (en) 1996-05-03 2011-11-29 Ian M. Penn Bifurcated stent and method for the manufacture and delivery of same
US5549662A (en) 1994-11-07 1996-08-27 Scimed Life Systems, Inc. Expandable stent using sliding members
US5637113A (en) 1994-12-13 1997-06-10 Advanced Cardiovascular Systems, Inc. Polymer film for wrapping a stent structure
US5546880A (en) 1994-12-29 1996-08-20 The Bf Goodrich Company Annular filamentary structures and methods of making
DE19508805C2 (en) 1995-03-06 2000-03-30 Lutz Freitag Stent for placement in a body tube with a flexible support structure made of at least two wires with different shape memory functions
EP0817657B1 (en) 1995-03-31 2003-08-20 Micro Interventional Systems, Inc. Single-lumen balloon catheter
BE1009278A3 (en) 1995-04-12 1997-01-07 Corvita Europ Guardian self-expandable medical device introduced in cavite body, and medical device with a stake as.
US6027516A (en) 1995-05-04 2000-02-22 The United States Of America As Represented By The Department Of Health And Human Services Highly elastic, adjustable helical coil stent
US5534007A (en) 1995-05-18 1996-07-09 Scimed Life Systems, Inc. Stent deployment catheter with collapsible sheath
US5700269A (en) 1995-06-06 1997-12-23 Corvita Corporation Endoluminal prosthesis deployment device for use with prostheses of variable length and having retraction ability
US6814748B1 (en) 1995-06-07 2004-11-09 Endovascular Technologies, Inc. Intraluminal grafting system
US5749883A (en) 1995-08-30 1998-05-12 Halpern; David Marcos Medical instrument
US5702418A (en) 1995-09-12 1997-12-30 Boston Scientific Corporation Stent delivery system
US6440097B1 (en) 1995-10-06 2002-08-27 Target Therapeutics, Inc. Balloon catheter with delivery side holes
US6689162B1 (en) 1995-10-11 2004-02-10 Boston Scientific Scimed, Inc. Braided composite prosthesis
US5758562A (en) 1995-10-11 1998-06-02 Schneider (Usa) Inc. Process for manufacturing braided composite prosthesis
US6375615B1 (en) 1995-10-13 2002-04-23 Transvascular, Inc. Tissue penetrating catheters having integral imaging transducers and their methods of use
GB9522332D0 (en) 1995-11-01 1996-01-03 Biocompatibles Ltd Braided stent
US5628788A (en) 1995-11-07 1997-05-13 Corvita Corporation Self-expanding endoluminal stent-graft
ES2131253T3 (en) 1995-11-14 1999-07-16 Schneider Europ Gmbh DEVICE FOR THE IMPLEMENTATION OF AN ENDOPROTESIS.
USD381932S (en) 1995-11-15 1997-08-05 Michael Walshe Flower arranging device
US5824040A (en) 1995-12-01 1998-10-20 Medtronic, Inc. Endoluminal prostheses and therapies for highly variable body lumens
US6428489B1 (en) 1995-12-07 2002-08-06 Precision Vascular Systems, Inc. Guidewire system
US20030069522A1 (en) 1995-12-07 2003-04-10 Jacobsen Stephen J. Slotted medical device
US5833632A (en) 1995-12-07 1998-11-10 Sarcos, Inc. Hollow guide wire apparatus catheters
US6203569B1 (en) 1996-01-04 2001-03-20 Bandula Wijay Flexible stent
US5749894A (en) 1996-01-18 1998-05-12 Target Therapeutics, Inc. Aneurysm closure method
JPH09215753A (en) 1996-02-08 1997-08-19 Schneider Usa Inc Self-expanding stent made of titanium alloy
US6334871B1 (en) 1996-03-13 2002-01-01 Medtronic, Inc. Radiopaque stent markers
US5824042A (en) 1996-04-05 1998-10-20 Medtronic, Inc. Endoluminal prostheses having position indicating markers
US5718159A (en) 1996-04-30 1998-02-17 Schneider (Usa) Inc. Process for manufacturing three-dimensional braided covered stent
US6592617B2 (en) 1996-04-30 2003-07-15 Boston Scientific Scimed, Inc. Three-dimensional braided covered stent
US5690120A (en) 1996-05-24 1997-11-25 Sarcos, Inc. Hybrid catheter guide wire apparatus
US6440088B1 (en) 1996-05-24 2002-08-27 Precision Vascular Systems, Inc. Hybrid catheter guide wire apparatus and method
US6017319A (en) 1996-05-24 2000-01-25 Precision Vascular Systems, Inc. Hybrid tubular guide wire for catheters
US5916194A (en) 1996-05-24 1999-06-29 Sarcos, Inc. Catheter/guide wire steering apparatus and method
JPH11510423A (en) 1996-05-29 1999-09-14 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Image guided surgery system
US5868754A (en) 1996-06-12 1999-02-09 Target Therapeutics, Inc. Medical retrieval device
US5797952A (en) 1996-06-21 1998-08-25 Localmed, Inc. System and method for delivering helical stents
US5769884A (en) 1996-06-27 1998-06-23 Cordis Corporation Controlled porosity endovascular implant
US6077295A (en) 1996-07-15 2000-06-20 Advanced Cardiovascular Systems, Inc. Self-expanding stent delivery system
DE69722720T2 (en) 1996-07-24 2004-05-13 Cordis Corp., Miami Lakes Balloon catheter and method of use
US5980514A (en) 1996-07-26 1999-11-09 Target Therapeutics, Inc. Aneurysm closure device assembly
HU217501B (en) 1996-07-31 2000-02-28 László Major Enlarging facing for blood-vessels
US5980530A (en) 1996-08-23 1999-11-09 Scimed Life Systems Inc Stent delivery system
US6123712A (en) 1996-08-23 2000-09-26 Scimed Life Systems, Inc. Balloon catheter with stent securement means
US5964797A (en) 1996-08-30 1999-10-12 Target Therapeutics, Inc. Electrolytically deployable braided vaso-occlusion device
US6302810B2 (en) 1996-09-09 2001-10-16 Sumitomo Rubber Industries, Ltd. Solid golf ball
US6553880B2 (en) 1996-09-16 2003-04-29 Sarcos, Lc Micromachining system
US6014919A (en) 1996-09-16 2000-01-18 Precision Vascular Systems, Inc. Method and apparatus for forming cuts in catheters, guidewires, and the like
US6254628B1 (en) 1996-12-09 2001-07-03 Micro Therapeutics, Inc. Intracranial stent
US5709702A (en) 1996-10-15 1998-01-20 Cogita; Giuseppe Surgical device for repairing aneurysms
US6325826B1 (en) 1998-01-14 2001-12-04 Advanced Stent Technologies, Inc. Extendible stent apparatus
US6395017B1 (en) 1996-11-15 2002-05-28 C. R. Bard, Inc. Endoprosthesis delivery catheter with sequential stage control
US6010529A (en) 1996-12-03 2000-01-04 Atrium Medical Corporation Expandable shielded vessel support
US6096052A (en) 1998-07-08 2000-08-01 Ovion, Inc. Occluding device and method of use
US5776142A (en) 1996-12-19 1998-07-07 Medtronic, Inc. Controllable stent delivery system and method
US7959664B2 (en) 1996-12-26 2011-06-14 Medinol, Ltd. Flat process of drug coating for stents
BE1010858A4 (en) 1997-01-16 1999-02-02 Medicorp R & D Benelux Sa Luminal endoprosthesis FOR BRANCHING.
US5957974A (en) 1997-01-23 1999-09-28 Schneider (Usa) Inc Stent graft with braided polymeric sleeve
US5735859A (en) 1997-02-14 1998-04-07 Cathco, Inc. Distally attachable and releasable sheath for a stent delivery system
US6395021B1 (en) 1997-02-26 2002-05-28 Applied Medical Resources Corporation Ureteral stent system apparatus and method
US5830229A (en) 1997-03-07 1998-11-03 Micro Therapeutics Inc. Hoop stent
US5911717A (en) 1997-03-17 1999-06-15 Precision Vascular Systems, Inc. Catheter deliverable thrombogenic apparatus and method
US6048360A (en) 1997-03-18 2000-04-11 Endotex Interventional Systems, Inc. Methods of making and using coiled sheet graft for single and bifurcated lumens
US5843168A (en) 1997-03-31 1998-12-01 Medtronic, Inc. Double wave stent with strut
US6524299B1 (en) 1997-04-09 2003-02-25 Target Therapeutics, Inc. Flow-directed catheter
US6240616B1 (en) 1997-04-15 2001-06-05 Advanced Cardiovascular Systems, Inc. Method of manufacturing a medicated porous metal prosthesis
US6159228A (en) 1997-05-20 2000-12-12 Frid; Noureddine Applicator for luminal endoprostheses
CA2235911C (en) 1997-05-27 2003-07-29 Schneider (Usa) Inc. Stent and stent-graft for treating branched vessels
BE1011180A6 (en) 1997-05-27 1999-06-01 Medicorp R & D Benelux Sa Luminal endoprosthesis AUTO EXPANDABLE.
US6056993A (en) 1997-05-30 2000-05-02 Schneider (Usa) Inc. Porous protheses and methods for making the same wherein the protheses are formed by spraying water soluble and water insoluble fibers onto a rotating mandrel
US5951599A (en) 1997-07-09 1999-09-14 Scimed Life Systems, Inc. Occlusion system for endovascular treatment of an aneurysm
US5928260A (en) 1997-07-10 1999-07-27 Scimed Life Systems, Inc. Removable occlusion system for aneurysm neck
EP0891752B1 (en) 1997-07-17 2005-01-12 Schneider (Europe) GmbH Stent and method for manufacturing such a stent
US6245103B1 (en) 1997-08-01 2001-06-12 Schneider (Usa) Inc Bioabsorbable self-expanding stent
US6174330B1 (en) 1997-08-01 2001-01-16 Schneider (Usa) Inc Bioabsorbable marker having radiopaque constituents
US6340367B1 (en) 1997-08-01 2002-01-22 Boston Scientific Scimed, Inc. Radiopaque markers and methods of using the same
ES2272007T3 (en) 1997-08-04 2007-04-16 Boston Scientific Limited OCLUSION SYSTEM FOR PREPARATION OF AN ANEURISM.
WO1999008607A1 (en) 1997-08-05 1999-02-25 Boston Scientific Limited Detachable aneurysm neck bridge
US5984957A (en) 1997-08-12 1999-11-16 Schneider (Usa) Inc Radially expanded prostheses with axial diameter control
US6322576B1 (en) 1997-08-29 2001-11-27 Target Therapeutics, Inc. Stable coil designs
US6860893B2 (en) 1997-08-29 2005-03-01 Boston Scientific Scimed, Inc. Stable coil designs
ES2290995T3 (en) 1997-09-24 2008-02-16 Med Institute, Inc. RADIALLY EXPANDABLE ENDOPROTESIS.
US6066149A (en) 1997-09-30 2000-05-23 Target Therapeutics, Inc. Mechanical clot treatment device with distal filter
US6074407A (en) 1997-10-14 2000-06-13 Target Therapeutics, Inc. Delivery catheter for occlusive implants
US6161399A (en) 1997-10-24 2000-12-19 Iowa-India Investments Company Limited Process for manufacturing a wire reinforced monolayer fabric stent
US6635068B1 (en) 1998-02-10 2003-10-21 Artemis Medical, Inc. Occlusion, anchoring, tensioning and flow direction apparatus and methods for use
AU754966B2 (en) 1998-02-12 2002-11-28 Thomas R. Marotta Endovascular prosthesis
US6022369A (en) 1998-02-13 2000-02-08 Precision Vascular Systems, Inc. Wire device with detachable end
US6623521B2 (en) 1998-02-17 2003-09-23 Md3, Inc. Expandable stent with sliding and locking radial elements
US6033436A (en) 1998-02-17 2000-03-07 Md3, Inc. Expandable stent
US6015432A (en) 1998-02-25 2000-01-18 Cordis Corporation Wire reinforced vascular prosthesis
US6206868B1 (en) 1998-03-13 2001-03-27 Arteria Medical Science, Inc. Protective device and method against embolization during treatment of carotid artery disease
AR017498A1 (en) 1998-03-13 2001-09-12 Arteria Medical Science Llc DEVICE FOR PROTECTION AGAINST EMBOLIZATIONS, IN ANGIOPLASTIA DE CAROTIDA
US6019778A (en) 1998-03-13 2000-02-01 Cordis Corporation Delivery apparatus for a self-expanding stent
US6423032B2 (en) 1998-03-13 2002-07-23 Arteria Medical Science, Inc. Apparatus and methods for reducing embolization during treatment of carotid artery disease
US6224609B1 (en) 1998-03-16 2001-05-01 Teramed Inc. Bifurcated prosthetic graft
EP0943300A1 (en) 1998-03-17 1999-09-22 Medicorp S.A. Reversible action endoprosthesis delivery device.
US6102942A (en) 1998-03-30 2000-08-15 Endovascular Technologies, Inc. Stent/graft deployment catheter with a stent/graft attachment mechanism
US6520983B1 (en) 1998-03-31 2003-02-18 Scimed Life Systems, Inc. Stent delivery system
US6063111A (en) 1998-03-31 2000-05-16 Cordis Corporation Stent aneurysm treatment system and method
US6264689B1 (en) 1998-03-31 2001-07-24 Scimed Life Systems, Incorporated Low profile medical stent
JPH11299901A (en) 1998-04-16 1999-11-02 Johnson & Johnson Medical Kk Stent and its manufacture
US5944728A (en) 1998-04-23 1999-08-31 Boston Scientific Corporation Surgical retrieval basket with the ability to capture and release material
DE19823623A1 (en) 1998-05-27 1999-12-02 Bosch Gmbh Robert Method and contact point for establishing an electrical connection
US6149680A (en) 1998-06-04 2000-11-21 Scimed Life Systems, Inc. Stent loading tool
US5980533A (en) 1998-06-09 1999-11-09 Scimed Life Systems, Inc. Stent delivery system
IL124958A0 (en) 1998-06-16 1999-01-26 Yodfat Ofer Implantable blood filtering device
US6210400B1 (en) 1998-07-22 2001-04-03 Endovasix, Inc. Flexible flow apparatus and method for the disruption of occlusions
US6547779B2 (en) 1998-07-22 2003-04-15 Endovasix, Inc. Flexible flow apparatus and method for the disruption of occlusions
US6139543A (en) 1998-07-22 2000-10-31 Endovasix, Inc. Flow apparatus for the disruption of occlusions
US6165194A (en) 1998-07-24 2000-12-26 Micrus Corporation Intravascular flow modifier and reinforcement device
US20020173839A1 (en) 1998-07-24 2002-11-21 Leopold Eric W. Intravascular flow modifier and reinforcement device with connected segments
US6656218B1 (en) 1998-07-24 2003-12-02 Micrus Corporation Intravascular flow modifier and reinforcement device
US7004962B2 (en) 1998-07-27 2006-02-28 Schneider (Usa), Inc. Neuroaneurysm occlusion and delivery device and method of using same
US6093199A (en) 1998-08-05 2000-07-25 Endovascular Technologies, Inc. Intra-luminal device for treatment of body cavities and lumens and method of use
US7235096B1 (en) 1998-08-25 2007-06-26 Tricardia, Llc Implantable device for promoting repair of a body lumen
US20130190856A1 (en) 1998-09-05 2013-07-25 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation
US6409683B1 (en) 1998-09-30 2002-06-25 Cordis Corporation Medical guidewire with improved coil attachment
JP2002525168A (en) 1998-09-30 2002-08-13 インプラ・インコーポレーテッド Introduction mechanism of implantable stent
US6340368B1 (en) 1998-10-23 2002-01-22 Medtronic Inc. Implantable device with radiopaque ends
JP2000126182A (en) 1998-10-27 2000-05-09 Mitani Sangyo Co Ltd Tumor diagnosing method
US7044134B2 (en) 1999-11-08 2006-05-16 Ev3 Sunnyvale, Inc Method of implanting a device in the left atrial appendage
US6214042B1 (en) 1998-11-10 2001-04-10 Precision Vascular Systems, Inc. Micro-machined stent for vessels, body ducts and the like
US6368557B1 (en) 1998-12-30 2002-04-09 Cardiovention, Inc. Integrated blood oxygenator and pump system having means for reducing manifold flooding
US6224829B1 (en) 1998-12-30 2001-05-01 Cadiovention, Inc. Integrated blood oxygenator and pump system having means for reducing fiber breakage
US6428747B1 (en) 1998-12-30 2002-08-06 Cardiovention, Inc. Integrated extracorporeal blood oxygenator, pump and heat exchanger system
US6379618B1 (en) 1998-12-30 2002-04-30 Cardiovention, Inc. Integrated blood oxygenator and pump system having means for reducing microbubble generation
US6454999B1 (en) 1998-12-30 2002-09-24 Cardiovention, Inc. Integrated blood pump and oxygenator system having extended blood flow path
US6464650B2 (en) 1998-12-31 2002-10-15 Advanced Cardiovascular Systems, Inc. Guidewire with smoothly tapered segment
FR2788216B1 (en) 1999-01-08 2001-03-30 Balt Extrusion DEVICE FOR SEALING AN ANEVRISM OR THE LIKE IN A BLOOD VESSEL LIKE AN ARTERY
US7018401B1 (en) 1999-02-01 2006-03-28 Board Of Regents, The University Of Texas System Woven intravascular devices and methods for making the same and apparatus for delivery of the same
US6248122B1 (en) 1999-02-26 2001-06-19 Vascular Architects, Inc. Catheter with controlled release endoluminal prosthesis
US6355051B1 (en) 1999-03-04 2002-03-12 Bioguide Consulting, Inc. Guidewire filter device
US20020169474A1 (en) 1999-03-08 2002-11-14 Microvena Corporation Minimally invasive medical device deployment and retrieval system
US6261316B1 (en) 1999-03-11 2001-07-17 Endologix, Inc. Single puncture bifurcation graft deployment system
IL128938A0 (en) 1999-03-11 2000-02-17 Mind Guard Ltd Implantable stroke treating device
US6673089B1 (en) 1999-03-11 2004-01-06 Mindguard Ltd. Implantable stroke treating device
US6287333B1 (en) 1999-03-15 2001-09-11 Angiodynamics, Inc. Flexible stent
US6350199B1 (en) 1999-03-16 2002-02-26 International Game Technology Interactive gaming machine and method with customized game screen presentation
US6646218B1 (en) 1999-03-29 2003-11-11 Key Technology, Inc. Multi-band spectral sorting system for light-weight articles
US6319275B1 (en) 1999-04-07 2001-11-20 Medtronic Ave, Inc. Endolumenal prosthesis delivery assembly and method of use
CA2370180C (en) 1999-04-15 2009-07-07 Smart Therapeutics, Inc. Intravascular stent and method of treating neurovascular vessel lesion
US6183410B1 (en) 1999-05-06 2001-02-06 Precision Vascular Systems, Inc. Radiation exposure device for blood vessels, body cavities and the like
US6146415A (en) 1999-05-07 2000-11-14 Advanced Cardiovascular Systems, Inc. Stent delivery system
US6918921B2 (en) 1999-05-07 2005-07-19 Salviac Limited Support frame for an embolic protection device
US6964672B2 (en) 1999-05-07 2005-11-15 Salviac Limited Support frame for an embolic protection device
ES2279757T3 (en) 1999-05-11 2007-09-01 Atrionix, Inc. BALL ANCHORING THREAD.
US6375676B1 (en) 1999-05-17 2002-04-23 Advanced Cardiovascular Systems, Inc. Self-expanding stent with enhanced delivery precision and stent delivery system
US6858034B1 (en) 1999-05-20 2005-02-22 Scimed Life Systems, Inc. Stent delivery system for prevention of kinking, and method of loading and using same
US6478778B1 (en) 1999-05-28 2002-11-12 Precision Vascular Systems, Inc. Apparatus for delivering fluids to blood vessels, body cavities, and the like
US20020169473A1 (en) 1999-06-02 2002-11-14 Concentric Medical, Inc. Devices and methods for treating vascular malformations
US6398802B1 (en) 1999-06-21 2002-06-04 Scimed Life Systems, Inc. Low profile delivery system for stent and graft deployment
AU6000200A (en) 1999-07-16 2001-02-05 Biocompatibles Limited Braided stent
US6245087B1 (en) 1999-08-03 2001-06-12 Embol-X, Inc. Variable expansion frame system for deploying medical devices and methods of use
DE19936980C1 (en) 1999-08-05 2001-04-26 Aesculap Ag & Co Kg Insertion catheter for vascular prostheses
US6689120B1 (en) 1999-08-06 2004-02-10 Boston Scientific Scimed, Inc. Reduced profile delivery system
ES2209503T3 (en) 1999-08-27 2004-06-16 Ev3 Inc. FOLDING MEDICAL DEVICE.
DE29915724U1 (en) 1999-09-07 1999-12-23 Angiomed Ag Stent delivery system
US6364895B1 (en) 1999-10-07 2002-04-02 Prodesco, Inc. Intraluminal filter
US6375670B1 (en) 1999-10-07 2002-04-23 Prodesco, Inc. Intraluminal filter
US6613075B1 (en) 1999-10-27 2003-09-02 Cordis Corporation Rapid exchange self-expanding stent delivery catheter system
US7226475B2 (en) 1999-11-09 2007-06-05 Boston Scientific Scimed, Inc. Stent with variable properties
US6416519B1 (en) 1999-11-15 2002-07-09 Vandusseldorp Gregg A. Surgical extraction device
US6264671B1 (en) 1999-11-15 2001-07-24 Advanced Cardiovascular Systems, Inc. Stent delivery catheter and method of use
US6368344B1 (en) 1999-12-16 2002-04-09 Advanced Cardiovascular Systems, Inc. Stent deployment system with reinforced inner member
US6443979B1 (en) 1999-12-20 2002-09-03 Advanced Cardiovascular Systems, Inc. Expandable stent delivery sheath and method of use
US6443971B1 (en) 1999-12-21 2002-09-03 Advanced Cardiovascular Systems, Inc. System for, and method of, blocking the passage of emboli through a vessel
US6402771B1 (en) 1999-12-23 2002-06-11 Guidant Endovascular Solutions Snare
US6575997B1 (en) 1999-12-23 2003-06-10 Endovascular Technologies, Inc. Embolic basket
US6280465B1 (en) 1999-12-30 2001-08-28 Advanced Cardiovascular Systems, Inc. Apparatus and method for delivering a self-expanding stent on a guide wire
US6322586B1 (en) 2000-01-10 2001-11-27 Scimed Life Systems, Inc. Catheter tip designs and method of manufacture
US6312458B1 (en) 2000-01-19 2001-11-06 Scimed Life Systems, Inc. Tubular structure/stent/stent securement member
US6622604B1 (en) 2000-01-31 2003-09-23 Scimed Life Systems, Inc. Process for manufacturing a braided bifurcated stent
US6325822B1 (en) 2000-01-31 2001-12-04 Scimed Life Systems, Inc. Braided stent having tapered filaments
US6312463B1 (en) 2000-02-01 2001-11-06 Endotex Interventional Systems, Inc. Micro-porous mesh stent with hybrid structure
US6602280B2 (en) 2000-02-02 2003-08-05 Trivascular, Inc. Delivery system and method for expandable intracorporeal device
CA2398912A1 (en) 2000-02-04 2001-08-09 Wilson-Cook Medical Inc. Stent introducer apparatus
CA2397980C (en) 2000-03-03 2009-08-04 Cook Incorporated Endovascular device having a stent
US6468301B1 (en) 2000-03-27 2002-10-22 Aga Medical Corporation Repositionable and recapturable vascular stent/graft
US6702843B1 (en) 2000-04-12 2004-03-09 Scimed Life Systems, Inc. Stent delivery means with balloon retraction means
US6592616B1 (en) 2000-04-28 2003-07-15 Advanced Cardiovascular Systems, Inc. System and device for minimizing embolic risk during an interventional procedure
US6334864B1 (en) 2000-05-17 2002-01-01 Aga Medical Corp. Alignment member for delivering a non-symmetric device with a predefined orientation
US6602271B2 (en) 2000-05-24 2003-08-05 Medtronic Ave, Inc. Collapsible blood filter with optimal braid geometry
US6572646B1 (en) 2000-06-02 2003-06-03 Advanced Cardiovascular Systems, Inc. Curved nitinol stent for extremely tortuous anatomy
US6964670B1 (en) 2000-07-13 2005-11-15 Advanced Cardiovascular Systems, Inc. Embolic protection guide wire
IL137326A0 (en) 2000-07-17 2001-07-24 Mind Guard Ltd Implantable braided stroke preventing device and method of manufacturing
US6613078B1 (en) 2000-08-02 2003-09-02 Hector Daniel Barone Multi-component endoluminal graft assembly, use thereof and method of implanting
US6773446B1 (en) 2000-08-02 2004-08-10 Cordis Corporation Delivery apparatus for a self-expanding stent
US6497711B1 (en) 2000-08-16 2002-12-24 Scimed Life Systems, Inc. Therectomy device having a light weight drive shaft and an imaging device
US6482221B1 (en) 2000-08-21 2002-11-19 Counter Clockwise, Inc. Manipulatable delivery catheter for occlusive devices (II)
US6726700B1 (en) 2000-08-21 2004-04-27 Counter Clockwise, Inc. Manipulatable delivery catheter for occlusive devices
US6652574B1 (en) 2000-09-28 2003-11-25 Vascular Concepts Holdings Limited Product and process for manufacturing a wire stent coated with a biocompatible fluoropolymer
US6589273B1 (en) 2000-10-02 2003-07-08 Impra, Inc. Apparatus and method for relining a blood vessel
US7037330B1 (en) 2000-10-16 2006-05-02 Scimed Life Systems, Inc. Neurovascular stent and method
US6893451B2 (en) 2000-11-09 2005-05-17 Advanced Cardiovascular Systems, Inc. Apparatus for capturing objects beyond an operative site utilizing a capture device delivered on a medical guide wire
US6679893B1 (en) 2000-11-16 2004-01-20 Chestnut Medical Technologies, Inc. Grasping device and method of use
US6582460B1 (en) 2000-11-20 2003-06-24 Advanced Cardiovascular Systems, Inc. System and method for accurately deploying a stent
BE1013757A6 (en) 2000-12-12 2002-07-02 Frid Noureddine Luminal endoprosthesis MODULAR.
US8192484B2 (en) 2000-12-12 2012-06-05 Cardiatis S.A. Stent for blood flow improvement
US20040088037A1 (en) 2000-12-27 2004-05-06 American Medical Systems, Inc. Method and apparatus for making a braided stent with spherically ended wires
US6699274B2 (en) 2001-01-22 2004-03-02 Scimed Life Systems, Inc. Stent delivery system and method of manufacturing same
US6623518B2 (en) 2001-02-26 2003-09-23 Ev3 Peripheral, Inc. Implant delivery system with interlock
JP4673987B2 (en) 2001-02-27 2011-04-20 株式会社トップ Stent and stent member
US8764817B2 (en) 2001-03-05 2014-07-01 Idev Technologies, Inc. Methods for securing strands of woven medical devices and devices formed thereby
WO2002071975A2 (en) 2001-03-13 2002-09-19 Yoram Richter Method and apparatus for stenting
US7294137B2 (en) 2001-03-27 2007-11-13 Boston Scientific Scimed Device for multi-modal treatment of vascular lesions
EP1372531A2 (en) 2001-03-30 2004-01-02 Terumo Kabushiki Kaisha Stent cover and stent
US6818006B2 (en) 2001-04-03 2004-11-16 Medtronic Vascular, Inc. Temporary intraluminal filter guidewire
US6866677B2 (en) 2001-04-03 2005-03-15 Medtronic Ave, Inc. Temporary intraluminal filter guidewire and methods of use
US7044958B2 (en) 2001-04-03 2006-05-16 Medtronic Vascular, Inc. Temporary device for capturing embolic material
US7011675B2 (en) 2001-04-30 2006-03-14 Boston Scientific Scimed, Inc. Endoscopic stent delivery system and method
US6551352B2 (en) 2001-05-03 2003-04-22 Bionx Implants, Inc. Method for attaching axial filaments to a self expanding stent
US6673100B2 (en) 2001-05-25 2004-01-06 Cordis Neurovascular, Inc. Method and device for retrieving embolic coils
US20020188314A1 (en) 2001-06-07 2002-12-12 Microvena Corporation Radiopaque distal embolic protection device
US6605110B2 (en) 2001-06-29 2003-08-12 Advanced Cardiovascular Systems, Inc. Stent with enhanced bendability and flexibility
US20030100945A1 (en) 2001-11-23 2003-05-29 Mindguard Ltd. Implantable intraluminal device and method of using same in treating aneurysms
IL144213A0 (en) 2001-07-09 2002-05-23 Mind Guard Ltd Implantable filter
CA2452953A1 (en) 2001-07-18 2003-01-30 The Research Foundation Of State University Of New York Stent vascular intervention device and method
US7572288B2 (en) 2001-07-20 2009-08-11 Microvention, Inc. Aneurysm treatment device and method of use
US20050021075A1 (en) 2002-12-30 2005-01-27 Bonnette Michael J. Guidewire having deployable sheathless protective filter
US6652508B2 (en) 2001-11-09 2003-11-25 Scimed Life Systems, Inc. Intravascular microcatheter having hypotube proximal shaft with transition
US6740105B2 (en) 2001-11-23 2004-05-25 Mind Guard Ltd. Expandable delivery appliance particularly for delivering intravascular devices
US7147656B2 (en) 2001-12-03 2006-12-12 Xtent, Inc. Apparatus and methods for delivery of braided prostheses
US7294146B2 (en) 2001-12-03 2007-11-13 Xtent, Inc. Apparatus and methods for delivery of variable length stents
AU2002351311A1 (en) 2001-12-06 2003-06-23 Thomas J. Clement Medical device
AU2002351156A1 (en) 2001-12-21 2003-07-15 Salviac Limited A support frame for an embolic protection device
US20030135265A1 (en) 2002-01-04 2003-07-17 Stinson Jonathan S. Prostheses implantable in enteral vessels
US20040068314A1 (en) 2002-01-16 2004-04-08 Jones Donald K. Detachable self -expanding aneurysm cover device
US6758885B2 (en) 2002-02-07 2004-07-06 Visteon Global Technologies, Inc. Screened carbon trap protection
US7887573B2 (en) 2002-02-22 2011-02-15 Boston Scientific Scimed, Inc. Method and apparatus for deployment of an endoluminal device
US7169170B2 (en) 2002-02-22 2007-01-30 Cordis Corporation Self-expanding stent delivery system
US7004964B2 (en) 2002-02-22 2006-02-28 Scimed Life Systems, Inc. Apparatus and method for deployment of an endoluminal device
US7118539B2 (en) 2002-02-26 2006-10-10 Scimed Life Systems, Inc. Articulating guide wire for embolic protection and methods of use
US6989024B2 (en) 2002-02-28 2006-01-24 Counter Clockwise, Inc. Guidewire loaded stent for delivery through a catheter
ATE378019T1 (en) 2002-03-05 2007-11-15 Salviac Ltd EMBOLIC FILTER AND RETRACTION LOOP SYSTEM
US7063707B2 (en) 2002-03-06 2006-06-20 Scimed Life Systems, Inc. Medical retrieval device
US7192434B2 (en) 2002-03-08 2007-03-20 Ev3 Inc. Vascular protection devices and methods of use
US20030176884A1 (en) 2002-03-12 2003-09-18 Marwane Berrada Everted filter device
US6866679B2 (en) 2002-03-12 2005-03-15 Ev3 Inc. Everting stent and stent delivery system
US20030187495A1 (en) 2002-04-01 2003-10-02 Cully Edward H. Endoluminal devices, embolic filters, methods of manufacture and use
US7195648B2 (en) 2002-05-16 2007-03-27 Cordis Neurovascular, Inc. Intravascular stent device
US7264632B2 (en) 2002-06-07 2007-09-04 Medtronic Vascular, Inc. Controlled deployment delivery system
US6833003B2 (en) 2002-06-24 2004-12-21 Cordis Neurovascular Expandable stent and delivery system
DE10233085B4 (en) 2002-07-19 2014-02-20 Dendron Gmbh Stent with guide wire
JP2004049585A (en) 2002-07-22 2004-02-19 Piolax Medical Device:Kk Stent type therapeutic instrument
US7722551B2 (en) 2002-08-09 2010-05-25 Terumo Kabushiki Kaisha Guide wire
US8518096B2 (en) 2002-09-03 2013-08-27 Lifeshield Sciences Llc Elephant trunk thoracic endograft and delivery system
US7001422B2 (en) 2002-09-23 2006-02-21 Cordis Neurovascular, Inc Expandable stent and delivery system
US7107105B2 (en) 2002-09-24 2006-09-12 Medtronic, Inc. Deployable medical lead fixation system and method
US7331973B2 (en) 2002-09-30 2008-02-19 Avdanced Cardiovascular Systems, Inc. Guide wire with embolic filtering attachment
US20040093012A1 (en) 2002-10-17 2004-05-13 Cully Edward H. Embolic filter frame having looped support strut elements
US6994721B2 (en) 2002-10-21 2006-02-07 Israel Henry M Stent assembly
US6814746B2 (en) 2002-11-01 2004-11-09 Ev3 Peripheral, Inc. Implant delivery system with marker interlock
US7169172B2 (en) 2002-11-01 2007-01-30 Counter Clockwise, Inc. Method and apparatus for caged stent delivery
US7001425B2 (en) 2002-11-15 2006-02-21 Scimed Life Systems, Inc. Braided stent method for its manufacture
FR2847155B1 (en) 2002-11-20 2005-08-05 Younes Boudjemline METHOD FOR MANUFACTURING A MEDICAL IMPLANT WITH ADJUSTED STRUCTURE AND IMPLANT OBTAINED THEREBY
US6849084B2 (en) 2002-12-31 2005-02-01 Intek Technology L.L.C. Stent delivery system
US7300460B2 (en) 2002-12-31 2007-11-27 Counter Clockwise, Inc. Bifurcated guidewire and methods of use
US7494497B2 (en) 2003-01-02 2009-02-24 Boston Scientific Scimed, Inc. Medical devices
US20080208160A9 (en) 2003-01-10 2008-08-28 Mawad Michel E Microcatheter including swellable tip
US7220271B2 (en) 2003-01-30 2007-05-22 Ev3 Inc. Embolic filters having multiple layers and controlled pore size
US7323001B2 (en) 2003-01-30 2008-01-29 Ev3 Inc. Embolic filters with controlled pore size
US20040172055A1 (en) 2003-02-27 2004-09-02 Huter Scott J. Embolic filtering devices
US8591540B2 (en) 2003-02-27 2013-11-26 Abbott Cardiovascular Systems Inc. Embolic filtering devices
US7438712B2 (en) 2003-03-05 2008-10-21 Scimed Life Systems, Inc. Multi-braid exterior tube
US7715896B2 (en) 2003-03-21 2010-05-11 Boston Scientific Scimed, Inc. Systems and methods for internal tissue penetration
US7771463B2 (en) 2003-03-26 2010-08-10 Ton Dai T Twist-down implant delivery technologies
US20050209672A1 (en) 2004-03-02 2005-09-22 Cardiomind, Inc. Sliding restraint stent delivery systems
ES2346059T3 (en) 2003-03-26 2010-10-08 Biosensors International Group Ltd. IMPLANT SUPPLY CATHETER WITH ELECTROLYTICALLY EROSIONABLE JOINTS.
US20040193179A1 (en) 2003-03-26 2004-09-30 Cardiomind, Inc. Balloon catheter lumen based stent delivery systems
US20040193208A1 (en) 2003-03-27 2004-09-30 Scimed Life Systems, Inc. Radiopaque embolic protection filter membrane
US7473271B2 (en) 2003-04-11 2009-01-06 Boston Scientific Scimed, Inc. Stent delivery system with securement and deployment accuracy
US7198637B2 (en) 2003-04-21 2007-04-03 Medtronic Vascular, Inc. Method and system for stent retention using an adhesive
US7331976B2 (en) 2003-04-29 2008-02-19 Rex Medical, L.P. Distal protection device
US7942892B2 (en) 2003-05-01 2011-05-17 Abbott Cardiovascular Systems Inc. Radiopaque nitinol embolic protection frame
US6969396B2 (en) 2003-05-07 2005-11-29 Scimed Life Systems, Inc. Filter membrane with increased surface area
US7093527B2 (en) 2003-06-10 2006-08-22 Surpass Medical Ltd. Method and apparatus for making intraluminal implants and construction particularly useful in such method and apparatus
US20040254628A1 (en) 2003-06-13 2004-12-16 Patrice Nazzaro One-branch stent-graft for bifurcated lumens
US20040260331A1 (en) 2003-06-20 2004-12-23 D'aquanni Peter Beta titanium embolic protection frame and guide wire
US7470282B2 (en) 2003-06-30 2008-12-30 Boston Scientific Scimed, Inc. Stent grip and system for use therewith
DE10335649A1 (en) 2003-07-30 2005-02-24 Jotec Gmbh Braid stent for implantation in a blood vessel
US7479157B2 (en) 2003-08-07 2009-01-20 Boston Scientific Scimed, Inc. Stent designs which enable the visibility of the inside of the stent during MRI
US7316692B2 (en) 2003-08-12 2008-01-08 Boston Scientific Scimed, Inc. Laser-cut clot puller
US20050049668A1 (en) 2003-08-29 2005-03-03 Jones Donald K. Self-expanding stent and stent delivery system for treatment of vascular stenosis
US7763012B2 (en) 2003-09-02 2010-07-27 St. Jude Medical, Cardiology Division, Inc. Devices and methods for crossing a chronic total occlusion
US8292943B2 (en) 2003-09-03 2012-10-23 Bolton Medical, Inc. Stent graft with longitudinal support member
WO2005025643A2 (en) 2003-09-04 2005-03-24 Secant Medical, Llc Endovascular snare for capture and removal of arterial emboli
US8048369B2 (en) 2003-09-05 2011-11-01 Ati Properties, Inc. Cobalt-nickel-chromium-molybdenum alloys with reduced level of titanium nitride inclusions
US20050060017A1 (en) 2003-09-15 2005-03-17 Fischell Robert E. Means and method for the treatment of cerebral aneurysms
US20050090888A1 (en) 2003-10-28 2005-04-28 Hines Richard A. Pleated stent assembly
US7763011B2 (en) 2003-12-22 2010-07-27 Boston Scientific Scimed, Inc. Variable density braid stent
JP4301935B2 (en) 2003-12-26 2009-07-22 テルモ株式会社 Device for retaining embolus member
US7275471B2 (en) 2003-12-29 2007-10-02 Surpass Medical Ltd. Mixed wire braided device with structural integrity
US7069835B2 (en) 2004-01-12 2006-07-04 Surpass Medical Ltd. Striped braided element
US7338512B2 (en) 2004-01-22 2008-03-04 Rex Medical, L.P. Vein filter
US7468070B2 (en) 2004-01-23 2008-12-23 Boston Scientific Scimed, Inc. Stent delivery catheter
US8591568B2 (en) 2004-03-02 2013-11-26 Boston Scientific Scimed, Inc. Medical devices including metallic films and methods for making same
US7901447B2 (en) 2004-12-29 2011-03-08 Boston Scientific Scimed, Inc. Medical devices including a metallic film and at least one filament
DE102004012351A1 (en) 2004-03-11 2005-09-29 pfm Produkte für die Medizin AG Device for recanalizing a cavity, organ or vessel
WO2005094725A1 (en) 2004-03-31 2005-10-13 Merlin Md Pte Ltd A method for treating aneurysms
US8715340B2 (en) 2004-03-31 2014-05-06 Merlin Md Pte Ltd. Endovascular device with membrane
US7909873B2 (en) 2006-12-15 2011-03-22 Soteira, Inc. Delivery apparatus and methods for vertebrostenting
US7766960B2 (en) 2004-04-30 2010-08-03 Novostent Corporation Delivery catheter that controls foreshortening of ribbon-type prostheses and methods of making and use
US8617234B2 (en) 2004-05-25 2013-12-31 Covidien Lp Flexible vascular occluding device
US8147534B2 (en) 2005-05-25 2012-04-03 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
US8628564B2 (en) 2004-05-25 2014-01-14 Covidien Lp Methods and apparatus for luminal stenting
AU2005247490B2 (en) 2004-05-25 2011-05-19 Covidien Lp Flexible vascular occluding device
US8267985B2 (en) 2005-05-25 2012-09-18 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
US20060206200A1 (en) 2004-05-25 2006-09-14 Chestnut Medical Technologies, Inc. Flexible vascular occluding device
US20050283220A1 (en) 2004-06-22 2005-12-22 Gobran Riad H Blood flow diverters for the treatment of intracranial aneurysms
US20050288766A1 (en) 2004-06-28 2005-12-29 Xtent, Inc. Devices and methods for controlling expandable prostheses during deployment
US7763065B2 (en) 2004-07-21 2010-07-27 Reva Medical, Inc. Balloon expandable crush-recoverable stent device
US9283099B2 (en) 2004-08-25 2016-03-15 Advanced Cardiovascular Systems, Inc. Stent-catheter assembly with a releasable connection for stent retention
US20070280850A1 (en) 2004-09-27 2007-12-06 Carlson James M Mri Compatible Devices
CA2585284C (en) 2004-11-10 2013-07-23 Boston Scientific Limited Atraumatic stent with reduced deployment force, method for making the same and method and apparatus for deploying and positioning the stent
US20060116713A1 (en) 2004-11-26 2006-06-01 Ivan Sepetka Aneurysm treatment devices and methods
US20070100321A1 (en) 2004-12-22 2007-05-03 Leon Rudakov Medical device
US20060155367A1 (en) 2005-01-07 2006-07-13 Hines Richard A Micro-pleated stent assembly
ATE554820T1 (en) 2005-01-24 2012-05-15 Makram R Ebeid BALLOON CATHETER FOR STENT POSITIONING IN A BLOOD VESSEL CURVE SEGMENT
TW200635566A (en) 2005-01-25 2006-10-16 Vnus Med Tech Inc Structures for permanent occlusion of a hollow anatomical structure
US8109941B2 (en) 2005-02-28 2012-02-07 Boston Scientific Scimed, Inc. Distal release retrieval assembly and related methods of use
EP1698907A1 (en) 2005-03-04 2006-09-06 Cardiatis Société Anonyme Interventional medical device for use in MRI
WO2006116636A1 (en) 2005-04-28 2006-11-02 The Cleveland Clinic Foundation Stent with integrated filter
US7854760B2 (en) 2005-05-16 2010-12-21 Boston Scientific Scimed, Inc. Medical devices including metallic films
US8273101B2 (en) 2005-05-25 2012-09-25 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
US20060276910A1 (en) 2005-06-01 2006-12-07 Jan Weber Endoprostheses
US7320702B2 (en) 2005-06-08 2008-01-22 Xtent, Inc. Apparatus and methods for deployment of multiple custom-length prostheses (III)
US20070073379A1 (en) 2005-09-29 2007-03-29 Chang Jean C Stent delivery system
US20070021816A1 (en) 2005-07-21 2007-01-25 The Research Foundation Of State University Of New York Stent vascular intervention device and methods for treating aneurysms
US20070060994A1 (en) 2005-09-12 2007-03-15 Gobran Riad H Blood flow diverters for the treatment of intracranial aneurysms
EP1769774A1 (en) 2005-10-03 2007-04-04 Noureddine Frid Radiopaque endoprostheses
WO2007039678A1 (en) 2005-10-05 2007-04-12 Balt Extrusion Safety catheter for fluid injection
CA2627554A1 (en) 2005-10-27 2007-05-03 Martin S. Dieck Partially covered stent devices and methods of use
US20070100414A1 (en) 2005-11-02 2007-05-03 Cardiomind, Inc. Indirect-release electrolytic implant delivery systems
EP1945152A4 (en) 2005-11-09 2010-01-06 Merlin Md Pte Ltd Medical device with non-circumferential surface portion
US7665466B2 (en) 2005-11-14 2010-02-23 Occlutech Gmbh Self-expanding medical occlusion device
US7225825B1 (en) 2005-12-15 2007-06-05 Hartman Brian T Valve seal and method of installing a valve seal
DE102006004123A1 (en) 2006-01-25 2007-08-02 Jotec Gmbh Feed system for the insertion of expandable stents into cardiac arteries uses a hand held grip
WO2007089897A2 (en) 2006-02-01 2007-08-09 The Cleveland Clinic Foundation Inflatable-deflatable passive exercise unit
WO2007095031A2 (en) 2006-02-13 2007-08-23 Bay Street Medical, Inc. System for delivering a stent
US8152833B2 (en) 2006-02-22 2012-04-10 Tyco Healthcare Group Lp Embolic protection systems having radiopaque filter mesh
CN101049266B (en) 2006-04-03 2010-11-17 孟坚 Medical use obstruction appliance, and manufacturing method
DE102006013770A1 (en) 2006-03-24 2007-09-27 Occlutech Gmbh Occlusion instrument and method for its production
US20090222035A1 (en) 2006-03-27 2009-09-03 Tel Hashomer Medical Research Infrastructure And S Intraluminal Mass Collector
US8092508B2 (en) 2006-03-30 2012-01-10 Stryker Corporation Implantable medical endoprosthesis delivery system
US9089404B2 (en) 2006-03-31 2015-07-28 Covidien Lp Embolic protection devices having radiopaque elements
JP5061181B2 (en) 2006-04-07 2012-10-31 ピナンブラ、インク System and method for occluding an aneurysm
GB0607761D0 (en) 2006-04-20 2006-05-31 Site Specific Therapies Ltd Variable density stent
US8690935B2 (en) 2006-04-28 2014-04-08 DePuy Synthes Products, LLC Stent delivery system with threaded engagement and method
US8632581B2 (en) 2006-07-10 2014-01-21 Cook Medical Technologies Llc Conformable end sealing stent
US20080033341A1 (en) 2006-08-04 2008-02-07 Bay Holdings Ltd. Methods and devices for reducing or blocking blood flow to a selected blood vessel or part thereof
EP2056746A2 (en) 2006-08-17 2009-05-13 NFOCUS Neuromedical Inc. Aneurysm covering devices and delivery devices
EP2056747A2 (en) 2006-08-17 2009-05-13 NFOCUS Neuromedical Inc. Isolation devices for the treatment of aneurysms
US20100179583A1 (en) 2006-09-11 2010-07-15 Carpenter Judith T Methods of deploying and retrieving an embolic diversion device
US20100179647A1 (en) 2006-09-11 2010-07-15 Carpenter Judith T Methods of reducing embolism to cerebral circulation as a consequence of an index cardiac procedure
JP2010503490A (en) 2006-09-15 2010-02-04 ボストン サイエンティフィック リミテッド Endoprosthesis with adjustable surface features
JP2010504820A (en) 2006-09-28 2010-02-18 クック・インコーポレイテッド Apparatus and method for repairing a thoracic aortic aneurysm
US20080269774A1 (en) 2006-10-26 2008-10-30 Chestnut Medical Technologies, Inc. Intracorporeal Grasping Device
US9622888B2 (en) 2006-11-16 2017-04-18 W. L. Gore & Associates, Inc. Stent having flexibly connected adjacent stent elements
CN101578078B (en) 2006-11-22 2013-01-02 印斯拜尔Md有限公司 Optimized stent jacket
US20100076317A1 (en) 2006-11-30 2010-03-25 Koninklijke Philips Electronics N.V. Catheter with ultrasound transducer and variable focus lens used in aneurysm assessment
US20080221666A1 (en) 2006-12-15 2008-09-11 Cardiomind, Inc. Stent systems
DE102007012964A1 (en) 2007-03-06 2008-09-11 Phenox Gmbh Implant for influencing blood flow
WO2008112076A1 (en) 2007-03-07 2008-09-18 Boston Scientific Scimed, Inc. Radiopaque polymeric stent
US20080255654A1 (en) 2007-03-22 2008-10-16 Bay Street Medical System for delivering a stent
BRPI0721499A2 (en) 2007-03-23 2013-01-08 Invatec Technology Ct Gmbh endoluminal prosthesis
DE102007015462A1 (en) 2007-03-30 2008-10-02 Acandis Gmbh & Co. Kg Implant and method and apparatus for producing such an implant
EP2144580B1 (en) 2007-04-09 2015-08-12 Covidien LP Stent delivery system
US8409270B2 (en) 2007-04-16 2013-04-02 Boston Scientific Scimed, Inc. Radiopaque compositions, stents and methods of preparation
US20080262590A1 (en) 2007-04-19 2008-10-23 Medtronic Vascular, Inc. Delivery System for Stent-Graft
DE102007019772B4 (en) 2007-04-26 2019-09-26 Acandis Gmbh Stent and method of making a stent
US8133268B2 (en) 2007-05-30 2012-03-13 Cordis Corporation Stent/fiber structural combinations
US20080300667A1 (en) 2007-05-31 2008-12-04 Bay Street Medical System for delivering a stent
JP5517070B2 (en) 2007-06-13 2014-06-11 クック・メディカル・テクノロジーズ・リミテッド・ライアビリティ・カンパニー Stent attachment for intravascular aneurysm repair
EP2165684B1 (en) 2007-07-06 2019-03-20 IR Medical Atelier Stent, microcatheter, continuous hoselike body braiding apparatus and process for manufacturing stent
US9144508B2 (en) 2007-07-19 2015-09-29 Back Bay Medical Inc. Radially expandable stent
US8092510B2 (en) 2007-07-25 2012-01-10 Cook Medical Technologies Llc Retention wire for self-expanding stent
US20100174309A1 (en) 2008-05-19 2010-07-08 Mindframe, Inc. Recanalization/revascularization and embolus addressing systems including expandable tip neuro-microcatheter
WO2009061882A1 (en) 2007-11-07 2009-05-14 Cook Incorporated Method and apparatus for introducing expandable intraluminal prosthesis
FR2926215B1 (en) 2008-01-14 2010-01-01 Balt Extrusion SYSTEM FOR PREVENTING ANEVISM OR THE LIKE IN A BLOOD VESSEL
WO2009105176A2 (en) 2008-02-19 2009-08-27 William Cook Europe Aps Coated endoluminal implant
DE102008010507B3 (en) 2008-02-22 2009-08-20 Acandis Gmbh & Co. Kg Stent and method of making such a stent
AU2009217354B2 (en) 2008-02-22 2013-10-10 Covidien Lp Methods and apparatus for flow restoration
US20110046720A1 (en) 2008-02-28 2011-02-24 Alon Shalev Apparatus and Method for Creating Arteriovenous Fistulas
US20090288000A1 (en) 2008-05-15 2009-11-19 Skintour Llc Interactive application for accessing information about a condition
US8333796B2 (en) 2008-07-15 2012-12-18 Penumbra, Inc. Embolic coil implant system and implantation method
DE202008009604U1 (en) 2008-07-17 2008-11-27 Sahl, Harald, Dr. Membrane implant for the treatment of cerebral artery aneurysms
US8353943B2 (en) 2008-08-29 2013-01-15 Cook Medical Technologies Llc Variable weave graft with metal strand reinforcement for in situ fenestration
US8144958B2 (en) 2008-09-11 2012-03-27 Carl Zeiss Meditec Ag Medical systems and methods
KR20100042478A (en) 2008-10-16 2010-04-26 (주) 태웅메디칼 A making method for the stent and the stent thereof
WO2010090348A1 (en) 2009-02-06 2010-08-12 学校法人慶應義塾 Stent to be used in tubular organ in vivo
DE102009020012A1 (en) 2009-05-05 2010-11-11 Acandis Gmbh & Co. Kg Device for releasing a self-expanding medical functional element
US9510855B2 (en) 2009-06-15 2016-12-06 Perflow Medical Ltd. Method and apparatus for allowing blood flow through an occluded vessel
US8936634B2 (en) 2009-07-15 2015-01-20 W. L. Gore & Associates, Inc. Self constraining radially expandable medical devices
US20110016427A1 (en) 2009-07-17 2011-01-20 Andre Gene Douen Systems, Methods and Articles For Managing Presentation of Information
US8863031B2 (en) 2009-07-17 2014-10-14 Andre Gene Douen Systems, methods and articles for managing presentation of information
WO2011014814A2 (en) 2009-07-30 2011-02-03 Boston Scientific Scimed, Inc. Stent delivery system
WO2011025887A1 (en) 2009-08-27 2011-03-03 Boston Scientific Scimed, Inc. Stent with variable cross section braiding filament and method for making same
CN101991477B (en) 2009-08-27 2014-03-26 上海微创医疗器械(集团)有限公司 Vascular reconstructive support frame
DE102009060228B4 (en) 2009-12-23 2014-12-04 Acandis Gmbh & Co. Kg Medical devices
CN102933161A (en) 2010-02-08 2013-02-13 萨帕斯医药有限公司 Method and device for treating cerebrovascular pathologies and delivery system therefor
WO2011100263A1 (en) 2010-02-10 2011-08-18 Exploramed Iii, Inc. Methods, systems and devices for treatment of cerebrospinal venous insufficiency and multiple sclerosis
DE102010018539A1 (en) 2010-04-28 2011-11-03 Acandis Gmbh & Co. Kg A method of manufacturing a medical device for endoluminal treatments and starting product for the manufacture of a medical device
US10271970B2 (en) 2010-08-03 2019-04-30 Cook Medical Technologies Llc Blood perfusion device
EP2603168B1 (en) 2010-08-10 2016-04-20 Cook Medical Technologies LLC Medical prostheses having bundled and non-bundled regions
US10166128B2 (en) 2011-01-14 2019-01-01 W. L. Gore & Associates. Inc. Lattice
WO2012135167A1 (en) 2011-03-31 2012-10-04 Cook Medical Technologies Llc Stent designs having enhanced radiopacity
US8728148B2 (en) 2011-11-09 2014-05-20 Cook Medical Technologies Llc Diameter reducing tie arrangement for endoluminal prosthesis
US20130123901A1 (en) 2011-11-14 2013-05-16 Robert A. Connor Stent with in situ determination of wall areas with differences in porosity
US9301831B2 (en) 2012-10-30 2016-04-05 Covidien Lp Methods for attaining a predetermined porosity of a vascular device
US9452070B2 (en) 2012-10-31 2016-09-27 Covidien Lp Methods and systems for increasing a density of a region of a vascular device
US9943427B2 (en) 2012-11-06 2018-04-17 Covidien Lp Shaped occluding devices and methods of using the same
US9157174B2 (en) 2013-02-05 2015-10-13 Covidien Lp Vascular device for aneurysm treatment and providing blood flow into a perforator vessel
US9907684B2 (en) 2013-05-08 2018-03-06 Aneuclose Llc Method of radially-asymmetric stent expansion

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998047447A1 (en) * 1997-04-23 1998-10-29 Dubrul William R Bifurcated stent and distal protection system
US20100318174A1 (en) * 1998-12-11 2010-12-16 Endologix, Inc. Implantable vascular graft
WO2006034140A2 (en) * 2004-09-17 2006-03-30 Cordis Neurovascular, Inc. Thin film devices for temporary or permanent occlusion of a vessel
US20070208415A1 (en) * 2006-03-06 2007-09-06 Kevin Grotheim Bifurcated stent with controlled drug delivery
WO2008005898A2 (en) * 2006-06-30 2008-01-10 Ev3 Endovascular, Inc. Medical devices with amorphous metals and methods therefor
US20120290067A1 (en) * 2011-05-11 2012-11-15 Tyco Healthcare Group Lp Vascular remodeling device

Also Published As

Publication number Publication date
EP2953552B1 (en) 2021-10-27
US20140222130A1 (en) 2014-08-07
US20160022451A1 (en) 2016-01-28
US9561122B2 (en) 2017-02-07
EP2953552A1 (en) 2015-12-16
US9157174B2 (en) 2015-10-13

Similar Documents

Publication Publication Date Title
US9561122B2 (en) Vascular device for aneurysm treatment and providing blood flow into a perforator vessel
US10952878B2 (en) Methods and systems for increasing a density of a region of a vascular device
US9907643B2 (en) Systems for attaining a predetermined porosity of a vascular device
JP6324371B2 (en) Devices and methods for treating aneurysms
JP5733759B2 (en) Intravascular device with directional expansion
US8262692B2 (en) Endovascular device
EP2614795B1 (en) Balloon-expandable/self-expanding prosthesis
US9750623B2 (en) Vascular stent with improved vessel wall apposition
US20190357925A1 (en) Systems and methods for catheter advancement
EP4059475A1 (en) Stent delivery device
JP2007524449A (en) Superelastic coiled stent
WO2010027363A1 (en) Endovascular device
CN110123501A (en) Blood vessel distensible devices
CN110123502A (en) Blood vessel distensible devices
CN110123500A (en) Blood vessel distensible devices
JP7043589B2 (en) Stent
JP2005342105A (en) Stent
JP2005342104A (en) Stent assembly
AU2013216587A1 (en) Vascular stenting for aneurysms

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14703465

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2014703465

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE